Department of Public Health
University of Copenhagen
16 March 2015
List of Publications – Elsebeth Lynge
Articles indexed in PubMed:
339
Articles NOT indexed in PubMed under
the name of Elsebeth Lynge:
111
2015
450: Sander BB, Vázques-Prada M, Rebolj M, Valentiner-Branth P, Lynge E. Mothers and their daughters’
use of preventive measures against cervical cancer. Scand J Public Health. 2015 Mar 5. pii:
1403494815574155. [Epub ahead of print]
449: Pearce NE, Blair A, Vineis P, Ahrens W, Andersen A, Anto JM, Armstrong BK, Baccarelli AA, Beland
FA, Berrington A, Bertazzi PA, Birnbaum LS, Brownson RC, Bucher JR, Cantor KP, Cardis E, Cherrie JW,
Christiani DC, Cocco P, Coggon D, Comba P, Demers PA, Dement JM, Douwes J, Eisen EA, Engel LS,
Fenske RA, Fleming LE, Fletcher T, Fontham E, Forastiere F, Frentzel-Beyme R, Fritschi L, Gerin M,
Goldberg M, Grandjean P, Grimsrud TK, Gustavsson P, Haines A, Hartge P, Hansen J, Hauptmann M,
Heederik D, Hemminki K, Hemon D, Hertz-Picciotto I, Hoppin JA, Huff J, Jarvholm B, Kang D, Karagas
MR, Kjaerheim K, Kjuus H, Kogevinas M, Kriebel D, Kristensen P, Kromhout H, Laden F, Lebailly P,
LeMasters G, Lubin JH, Lynch CF, Lynge E, 't Mannetje A, McMichael AJ, McLaughlin JR, Marrett L,
Martuzzi M, Merchant JA, Merler E, Merletti F, Miller A, Mirer FE, Monson R, Nordby KK, Olshan AF,
Parent ME, Perera FP, Perry MJ, Pesatori AC, Pirastu R, Porta M, Pukkala E, Rice C, Richardson DB, Ritter
L, Ritz B, Ronckers CM, Rushton L, Rusiecki JA, Rusyn I, Samet JM, Sandler DP, de Sanjose S,
Schernhammer E, Seniori Constantini A, Seixas N, Shy C, Siemiatycki J, Silvermann DT, Simonato L, Smith
AH, Smith MT, Spinelli JJ, Spitz MR, Stallones L, Stayner LT, Steenland K, Stenzel M, Stewart BW, Stewart
PA, Symanski E, Terracini B, Tolbert PE, Vainio H, Vena J, Vermeulen R, Victora CG, Ward EM, Weinberg
CR, Weisenburger D, Wesseling C, Weiderpass E, Zahm SH. IARC Monographs: 40 Years of Evaluating
Carcinogenic Hazards to Humans. Environ Health Perspect. 2015 Feb 24. [Epub ahead of print]
448: Reijula J, Kjaerheim K, Lynge E, Martinsen JI, Rejula K, Sparén P, Tryggvadottir L, Weiderpass E,
Pukkala E. Cancer incidence among waiters and waitresses – 45 years of follow-up in five Nordic countries.
Scand J Publ Health 2015 Jan 6. Pii 1403494814565130 [Epubl ahead of print].
447: Andersen SB, Törnberg S, Kilpeläinen S, Lynge E, Njor SH, von Euler-Chelpin M. Measuring the
burden of interval cancers in long-standing screening mammography programmes. J Med Screen 2015 Jan 9.
Pii 0969141314560386 [Epubl ahead of print].
2014
446: Frederikssen ME, Njor SH, Lynge E, Rebolj M. Psychological effects of diagnosis and treatment of
cervical intraepithelial neoplasia: a systematic review. 2014 Dec 15. Sex Transm Infect. doi:10.1136/sextrans2014-051754
445: Hammer T, Lynge E, Djurhus GW, Joensen JE, Køtlum JE, Hansen SO, Sander BB, Mogensen O, Rebolj
M. Cervical cancer screening in the Faroe Islands. Acta Oncol 2014. Posted online December 15 2014
(doi:10.3109/0284186X.2014.986287)
444: Cook MB, Guenel P, Gapstur SM, van den Brandt PA, Michels KB, Casagrande JT, Cooke R, Van Den
Eeden SK, Ewertz M, Falk RT, Gaudet MM, Gkiokas G, Habel LA, Hsing AW, Johnson K, Kolonel LN, La
Vecchia C, Lynge E, Lubin JH, McCormack VA, Negri E, Olsson H, Parisi D, Petridou ET, Riboli E, Sesso
HD, Swerdlow A, Thomas DB, Willett WC, Brinton LA. Tobacco and alcohol in relation to male breast
cancer: an analysis of the male breast cancer pooling project consortium. Cancer Epidemiol Biomarkers Prev.
2014 Dec 16. pii: cebp.1009.2014. [Epub ahead of print]
443: Njor SH, Schwartz W, Blichert-Toft M, Lynge E. Decline in breast cancer mortality: How much is
attributable to screening? J Med Screen 2014 Dec 9. Pii: 0969141313563632 [Epub ahead of print]
442: Rebolj M, Lynge E, Ejegod D, Junge J, Preisler S, Rygaard C, Bonde J. Comparison of three Human
Papillomavirus DNA assays and one mRNA assay in women with abnormal cytology. Gynecol Oncol. 2014
Oct 23. pii: S0090-8258(14)01398-5. doi: 10.1016/j.ygyno.2014.10.014. Epub 2014 Oct 23.
441: Andersen SB, Törnberg S, Lynge E, von Euler-Chelpin M, Njor SH. A simple way to measure the burden
of interval cancers in breast cancer screening. BMC Cancer 2014 Oct 24;14(1):782.
440: Dugué PA, Rebolj M, Hallas J, Garred P, Lynge E. Risk of cervical cancer in women with autoimmune
diseases, in relation with their use of immunisuppressants and screening: Population-based cohort study. Int J
Cancer 2014 Sep 13. doi: 10.1002/ijc.29209. Epub 2014 Sep 24.
439: Dugué PA, Lynge E, Rebolj M. Increased risk of high-grade squamous intraepithelial lesions in systemic
lupus erythematosus. Additional data from Denmark. Autoimmun Rev 2014; pii: S1568-9972(14)00148-7.
doi: 10.1016/j.autrev.2014.08.004. Epub 2014 Aug 20.
438: Ponti A, Lynge E, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Mano MP, Kawai
M, Scharpantgen A, Fracheboud J, Hofvind S, Vidal C, Ascunce N, Salas D, Bulliard J-L, Segnan N,
Kerlikowske K, Taplin S, and the ICSN DCIS Working Group. International variation in management of
screen-detected ductal carcinoma in situ of the breast. Eur J Cancer 2014 Oct;50(15):2695-704.
437: Lynge E, Kragstrup J. Clinical and ethical differences between diagnosing and screening. Ugeskr Laeger
2014;176. Pii:V03140188.
436: Bonde J, Rebolj M, Ejegod DM, Preisler S, Lynge E, Rygaard C. HPV prevalence and genotype
distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human
Papillomavirus genotype microarray system. BMC Infect Dis. 2014 Jul 26;14(1):413. Doi: 10.1186/14712334-14-413.
435: Paci E, Broeders M, Hofvind S, Puliti D, Duffy SW, the EUROSCREEBN Working Group. European
breast cancer service screening outcomes. A first balance sheet of the benefits and harms. Cancer Epidemiol
Biomarker Prevent 2014;23:159-63.
434: Christiansen P, Vejborg I, kroman N, Holten I, Garne JP, Vedsted P, Møller S, Lynge E. Comments to
the paper: Influence of mammography screening on use of mastectomies in Denmark. Acta Oncol, 2014 Jun 1;
1-2 Epub 2014 Jun 1.
433: Talibov M, Kautiainen S, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Weiderpass E, Tryggvadottit L,
Kauppinen T, Kyyrönen P, Pukkala E. Occupational Exposure to Solvents and Acute Myeloid Leukemia: A
Population-Based Case-Control Study in Nordic countries. Scand J Work Environ Health 2014;40:511-7.
432: Lynge E, Rygaard C, Baillet M V-P, Dugué P-A, Sander BB, Bonde J, Rebolj M. Cervical cancer
screening at crossroads. APMIS 2014;122:667-73.
431: Vlaanderen J, Straif K, Ruder A, Blair A, Hansen J, Lynge E, Charbotel B, Loomis D, Kauppinen T,
Kyyronen P, Pukkala E, Weiderpass E, Gula N. Tetrachloroethylene exposure and bladder cancer risk: A
mete-analysis of dry-cleaning-worker studies. Environ Health Perspec 2014;122:661-6.
430: Pukkala E, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Tryggvadottir L, Sparén P, Demers PA.
Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries. Occup Environ Med
2014;71:398-404. Epub 2014 Feb 6.
2
429: Sander BB, Rebolj M, Lynge E. Trends of cervical cancer in Greenland: A 60-year overview. Anta
Oncol 2014;53:452-61.
428: Christiansen P, Vejborg I, Kroman N, Holten I, Garne JP, Vedsted P, Møller S, Lynge E. Position
paper: Breast cancer screening, diagnosis, and treatment in Denmark. Acta Oncol. 2014 Feb 5: 53:433-44.
427: Lam JU, Rebolj M, Dugué PA, Bonde, J, von Euler-Chelpin M, Lynge E. Condom use in prevention
of Human papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies. J
Med Screen. 2014 Jan 31: 30-50.
426: Kristensson JH, Sander BB, von Euler-Chelpin M, Lynge E. Predictors of non-participation in
cervical screening in Denmark. Cancer Epidemiol 2014 Jan 18. pii: S1877-7821(13)00193-8. doi:
10.1016/j.canep.2013.12.007. Epub 2014 Jan 18.
425: Rebolj M, Preisler S, Ejegod DM, Rygaard C, Lynge E, Bonde J. Disagreement between human
papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.
Plos One 2014 Jan 20;9(1):e86835. doi: 10.1371/journal.pone.0086835. eCollection 2014 Jan 20.
424: Andersen ZJ, Baker JL, Bihrmann K, Vejborg I, Sørensen TIA, Lynge E. Birth weight, childhood
body mass index and height in relation to mammographic density and breast cancer: a register based
cohort study. Breast Cancer Res 2014;16:R4 doi:10.1186/bcr3596, Published: 20 January 2014.
2013
423: Lynge E, Kragstrup J, Bjerrum L, Rebolj M. Incidence of genital warts in young Danish women. Clin
Infect Dis. 2014 Feb;58(4):601-2. doi: 10.1093/cid/cit754. Epub 2013 Nov 18.
422: Dugué PA, Lynge E, Rebolj M. Mortality of non-participants in cervical screening: Register-based
cohort study. Int J Cancer. 2013 Nov 8. doi:10.1002/ijc.28586. [Epub ahead of print]
421: Rask J, Lynge E, Franzmann M, Hansen B, Hjortebjerg A, Rygaard C, Schledermann D, Wåhlin A,
Rebolj M. Impact of technology on cytology outcome in cervical cancer screening of young and older
women. Int J Cancer. 2014 May 1;134(9):2168-79. doi: 10.1002/ijc.28532. Epub 2013 Oct 24.
420: Hellmann SS, Lynge E, Schwartz W, Vejborg I, Njor SH. Mammographic density in birth cohorts of
Danish women: a longitudinal study. BMC Cancer. 2013 Sep 5;13:409. doi: 10.1186/1471-2407-13-409.
419: Njor SH, Garne JP, Lynge E. Over-diagnosis estimate from The Independent UK Panel on Breast Cancer
Screening is based on unsuitable data. J Med Screen 2013;20:104-5.
418: Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai
M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard J-L, Tomatis M,
Kerlikowske K, Taplin S. Variations in detection of ductal carcinoma in situ (DCIS) during screening
mammography. A survey within the International Cancer Screening Network (ICSN). Eur J Cancer
2014;50:185-92.
417: Dugué PA, Rebolj M, Lynge E. Lead time and down-staging in the survival of cervical cancer cases
detected by screening. Prev Med. 2013 Oct;57(4):403. doi:10.1016/j.ypmed.2013.07.025. Epub 2013 Aug
14.
416: Rebolj M, Preisler S, Ejegod DM, Bonde JH, Rygaard C, Lynge E. Prevalence of Human
Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA Assay. J Mol
Diagn. 13 Sep;15(5):670-7. doi:10.1016/j.jmoldx.2013.04.002. Epub 2013 Jul 1.
415: Preisler S, Rebolj M, Untermann A, Ejegod DM, Lynge E, Rygaard C, Bonde J. Prevalence of Human
3
Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV
Real- Time PCR Assay. PLoS One. 2013;8(3):e59765. doi: 10.1371/journal.pone.0059765. Epub 2013
Mar 22.
414: Barken SS, Lynge E, Andersen ES, Rebolj M. Long-term adherence to follow-up after treatment of
cervical intraepithelial neoplasia: nationwide population-based study. Acta Obstet Gynecol Scand. 2013 Feb
19. doi: 10.1111/aogs.12116. Epub 2013 Mar 12.
413: Njor SH, Olsen AH, Blichert-Toft M, Schwartz W, Vejborg I, Lynge E. Overdiagnosis in
screening mammography in Denmark: population based cohort study. BMJ 2013;346:f1064. doi:
http://dx.doi.org/10.1136/bmj.f1064
2012
412: Rebolj M, Lynge E. Human Papillomavirus testing in primary screening: Human Papillomavirus testing
in primary screening: Current evidence. In: Takač I (ed.). Recent advances in cervical cancer. Kerala:
Transworld Research Network, 2012, pages 55-67.
411: Guha N, Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L,
Baan R, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.
Carcinogenicity of trichloroethylene, tetrachloroethylene, some other chlorinated solvents, and their
metabolites. Lancet Oncol. 2012 Dec;13(12):1192-3.
410: Goldman B, Rebolj M, Rygaard C, Preisler S, Ejegod DM, Lynge E, Bonde J. Patterns of cervical
coinfection with multiple human papilloma virus types in a screening population in Denmark. Vaccine.
2013 Jan 10. doi:pii: S0264-410X(13)00013-3. 10.1016/j.vaccine.2012.12.084. Epub 2013 Jan 10.
409: Dugué PA, Rebolj M, Garred P, Lynge E. Immunosuppression and risk of cervical cancer. Expert Rev
Anticancer Ther. 2013 Jan;13(1):29-42. doi: 10.1586/era.12.159.
408: European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, Segnan
N, Atkin W, Halloran S, Lynge E, et al. European guidelines for quality assurance in colorectal cancer
screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013
Jan;45(1):51-9. doi: 10.1055/s-0032-1325997. Epub 2012 Dec 4.
407: Tverborgvik T, Clausen LB, Thorsted BL, Mikkelsen S, Lynge E. Intergenerational educational
mobility in Denmark. Scand J Educational Res. 2013;57(5):544-60. Epub 2012 Oct 8.
406: Giordano L, Cogo C, Patnick J, Paci E; Euroscreen Working Group. Communicating the balance sheet
in breast cancer screening. J Med Screen. 2012;19 Suppl 1:67-71.
405: Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Törnberg S;
EUNICE Project and Euroscreen Working Groups. False-positive results in mammographic screening for
breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen.
2012;19 Suppl 1:57-66.
404: Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E; EUROSCREEN
Working Group. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature
review. J Med Screen. 2012;19 Suppl 1:42-56.
403: Njor S, Nyström L, Moss S, Paci E, Broeders M, Segnan N, Lynge E; Euroscreen Working Group.
Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality
4
studies. J Med Screen. 2012;19 Suppl 1:33-41.
402: Moss SM, Nyström L, Jonsson H, Paci E, Lynge E, Njor S, Broeders M; Euroscreen Working Group.
The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J
Med Screen. 2012;19 Suppl 1:26-32.
401: Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci
E; EUROSCREEN Working Group. The impact of mammographic screening on breast cancer
mortality in Europe: a review of observational studies. J Med Screen. 2012;19 Suppl 1:14-25.
400: Paci E; EUROSCREEN Working Group. Summary of the evidence of breast cancer service
screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen.
2012;19 Suppl 1:5-13.
399: Talibov M, Kautiainen S, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass
E, Pukkala E. Occupation and Leukemia in Nordic Countries. J Occup Environ Med. 2012 Oct 30. [Epub
ahead of print]
398: Rebolj M, Pribac I, Frederiksen ME, Lynge E. The Problem of False-Positive Human Papillomavirus
DNA Tests in Cervical Screening. Curr Pharm Des. 2012 Sep 24. [Epub ahead of print]
397: Barken SS, Rebolj M, Lynge E, Junge J, Rygaard C. Outcomes in cervical screening using various
cytology technologies: What's age got to do with it? Eur J Cancer Prev. 2012 Sep 12. [Epub ahead of
print]
396: Domingo L, Jacobsen KK, von Euler-Chelpin M, Vejborg I, Schwartz W, Sala M, Lynge E.
Seventeen- years overview of breast cancer inside and outside screening in Denmark. Acta Oncol. 2012
Sep 3. [Epub ahead of print]
395: Lynge E, Njor SH, Olsen AH, Waaseth M, Braaten T, Lund E, Kumle M. Breast cancer mortality in
Norway after the introduction of mammography screening. Int J Cancer. 2012 Aug 30. doi:
10.1002/ijc.27809. [Epub ahead of print]
394: Pallesen PB, Lynge E. Employment effects of the Danish rehabilitation benefit. Scand J Public Health.
2012 Jun;40(4):325-32.
393: Clemmensen KK, Lynge E, Clemmensen IH. Nationwide tobacco surveys and sales data in Denmark
from 1920 to 2010. Dan Med J. 2012 Jun;59(6):A4448.
392: Olsen AH, Lynge E, Njor SH, Kumle M, Waaseth M, Braaten T, Lund E. Breast cancer mortality in
Norway after the introduction of mammography screening. Int J Cancer. 2013 Jan 1;132(1):208-14. doi:
10.1002/ijc.27609. Epub 2012 May 14.
391: Frederiksen ME, Lynge E, Rebolj M. Women's preferences regarding options for management of
atypical, borderline and low-grade cervical abnormalities. Cytopathology. 2012 Jun;23(3):201. doi:
10.1111/j.1365-2303.2012.00967.x. Epub 2012 Mar 19.
390: Lynge E. [Now two out of three cancer patients are alive a year after the diagnosis]. Ugeskr Laeger.
2012 Feb 20;174(8):475. Danish.
389: Dugué PA, Lynge E, Bjerregaard B, Rebolj M. Non-participation in screening: the case of cervical
cancer in Denmark. Prev Med. 2012 Mar-Apr;54(3-4):266-9. Epub 2012 Jan 24.
388: Kolstad HA, Ebbehøj N, Bonde JP, Lynge E, Albin M. [Health effects following occupational
styrene exposure in the reinforced plastics industry]. Ugeskr Laeger. 2012 Jan 30;174(5):267-70. Danish.
5
387: Lynge E, Rygaard C, Rebolj M, Bonde J. Prøv et offentligt/privat forskningssamarbejde. Ugeskrift
Læger. 2012 Nov;174(44):2731. Debat/Replik.
2011
386: Behrens T, Lynge E, Cree I, Lutz JM, Eriksson M, Guénel P, Merletti F, Morales-Suarez-Varela
M, Afonso, N, Stengrevics A, Stang A, Févotte J, Sabroe S, Llopis-González A, Gorini G, Hardell L,
Ahrens W. Occupational exposure to endocrine-disrupting chemicals and the risk of uveal melanoma.
Scand J Work Environ Health. 2012 Sep;38(5):476-83. doi: 10.5271/sjweh.3265. Epub 2011 Dec 17.
385: Sander BB, Rebolj M, Valentiner-Branth P, Lynge E. Introduction of human papillomavirus vaccination
in Nordic countries. Vaccine. 2012 Feb 14;30(8):1425-33. Epub 2011 Dec 7. Review.
384: Behrens T, Lynge E, Cree I, Lutz JM, Eriksson M, Guénel P, Merletti F, Morales-Suarez-Varela M,
Afonso N, Stengrevics A, Févotte J, Sabroe S, Llopis-González A, Gorini G, Hardell L, Stang A, Ahrens
W. Pesticide exposure in farming and forestry and the risk of uveal melanoma. Cancer Causes Control.
2012 Jan;23(1):141-51. Epub 2011 Nov 4.
383: Verhoeven RH, Kiemeney LA, Coebergh JW, Weiderpass E, Kjaerheim K, Martinsen JI, Lynge
E, Pukkala E. Occupation and scrotal cancer: results of the NOCCA study. Acta Oncol. 2011
Nov;50(8):1244-6.
382: Rebolj M, Njor SH, Lynge E. Restriction of human papillomavirus DNA testing in primary
cervical screening to women above age 30: systematic review. Eur J Cancer Prev. 2012 Jan;21(1):7381. Review.
381: Frederiksen ME, Lynge E, Rebolj M. What women want. Women's preferences for the management
of low-grade abnormal cervical screening tests: a systematic review. BJOG. 2012 Jan;119(1):7-19. doi:
10.1111/j.1471-0528.2011.03130.x. Epub 2011 Sep 6. Review.
380: Lynge E, Braaten T, Njor SH, Olsen AH, Kumle M, Waaseth M, Lund E. Mammography activity in
Norway 1983 to 2008. Acta Oncol. 2011 Oct;50(7):1062-7. Epub 2011 Aug 11.
379: Von Euler-Chelpin M, Lynge E, Rebolj M. Register-based studies of cancer screening effects. Scand
J Public Health. 2011 Jul;39(7 Suppl):158-64.
378: Lynge E. Occupational mortality. Scand J Public Health. 2011 Jul;39(7 Suppl):153-7. Review.
377: Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011
Jul;39(7 Suppl):30-3.
376: Rebolj M, Lynge E, Bonde J. Human papillomavirus testing and genotyping in cervical screening. Expert
Rev Anticancer Ther. 2011 Jul;11(7):1023-31. Review.
375: Riska A, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala
E. Occupation and risk of primary fallopian tube carcinoma in Nordic countries. Int J Cancer. 2012 Jul
1;131(1):186-92. doi: 10.1002/ijc.26337. Epub 2011 Aug 30.
374: Lynge E, Törnberg S, von Karsa L, Segnan N, van Delden JJ. Determinants of successful
implementation of population-based cancer screening programmes. Eur J Cancer. 2012 Mar;48(5):743-8.
Epub 2011 Jul 23.
373: Barken SS, Rebolj M, Andersen ES, Lynge E. Frequency of cervical intraepithelial neoplasia treatment
in a well-screened population. Int J Cancer. 2012 May 15;130(10):2438-44. doi: 10.1002/ijc.26248. Epub
2011 Aug 20.
6
372: Pallesen PB, Lynge E. Intentions and realities in rehabilitation service in Denmark. J Soc Work Disabil
Rehabil. 2011;10(2):82-95.
371: Vejborg I, Mikkelsen E, Garne JP, Bak M, Lernevall A, Mogensen NB, Schwartz W, Lynge
E. Mammography screening in Denmark. Dan Med Bull. 2011 Jun;58(6):C4287. Review.
370: Rebolj M, Bonde J, Njor SH, Lynge E. Human papillomavirus testing in primary cervical screening
and the cut-off level for hybrid capture 2 tests: systematic review. BMJ. 2011 May 23;342:d2757. doi:
10.1136/bmj.d2757. Review.
369: Lynge E, Tinnerberg H, Rylander L, Romundstad P, Johansen K, Lindbohm ML, Heikkilä P, Westberg
H, Clausen LB, Piombino A, Thorsted BL. Exposure to tetrachloroethylene in dry cleaning shops in the
Nordic countries. Ann Occup Hyg. 2011 May;55(4):387-96. Epub 2011 Feb 3.
368: Utzon-Frank N, Vejborg I, von Euler-Chelpin M, Lynge E. Balancing sensitivity and specificity:
sixteen years of experience from the mammography screening programme in Copenhagen, Denmark.
Cancer Epidemiol. 2011 Oct;35(5):393-8. Epub 2011 Jan 15.
2010
367: Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, Avnstrøm S, Langholz
E, O'Morain C, Lynge E, Munkholm P. E-health empowers patients with ulcerative colitis: a
randomised controlled trial of the web-guided 'Constant-care' approach. Gut. 2010 Dec;59(12):165261.
366: Dowling EC, Klabunde C, Patnick J, Ballard-Barbash R; International Cancer Screening Network
(ICSN). Breast and cervical cancer screening programme implementation in 16 countries. J Med Screen.
2010;17(3):139-46.
365: Kjaerheim K, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, Weiderpass
E, Pukkala E. Effects of occupation on risks of avoidable cancers in the Nordic countries. Eur J
Cancer. 2010 Sep;46(14):2545-54.
364: Rebolj M, Pribac I, Lynge E. False-positive Human Papillomavirus DNA tests in cervical screening: it
is all in a definition. Eur J Cancer. 2011 Jan;47(2):255-61.
363: Behrens T, Lynge E, Cree I, Sabroe S, Lutz JM, Afonso N, Eriksson M, Guénel P, Merletti F,
Morales- Suarez-Varela M, Stengrevics A, Févotte J, Llopis-González A, Gorini G, Sharkova G, Hardell L,
Ahrens W. Occupational exposure to electromagnetic fields and sex-differential risk of uveal melanoma.
Occup Environ Med. 2010 Nov;67(11):751-9. Epub 2010 Aug 25.
362: Villeneuve S, Cyr D, Lynge E, Orsi L, Sabroe S, Merletti F, Gorini G, Morales-Suarez-Varela M, Ahrens
W, Baumgardt-Elms C, Kaerlev L, Eriksson M, Hardell L, Févotte J, Guénel P. Occupation and occupational
exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe. Occup
Environ Med. 2010 Dec;67(12):837-44. Epub 2010 Aug 25.
361: Johansen K, Andersen JS, Mikkelsen S, Lynge E. Decision making and co-operation between
stakeholders within the process of sick leave. A case study in a Danish municipality. J Interprof Care. 2011
Jan;25(1):59-65. Epub 2010 Aug 26.
360: Njor SH, Hallas J, Schwartz W, Lynge E, Pedersen AT. Type of hormone therapy and risk
of misclassification at mammography screening. Menopause. 2011 Feb;18(2):171-7.
359: Lancucki L, Fender M, Koukari A, Lynge E, Mai V, Mancini E, Onysko J, Ronco G, Tornberg S,
7
Vessey M, Patnick J. A fall-off in cervical screening coverage of younger women in developed countries. J
Med Screen. 2010;17(2):91-6.
358: Rebolj M, Lynge E. Incomplete follow-up of positive HPV tests: overview of randomised controlled
trials on primary cervical screening. Br J Cancer. 2010 Jul 27;103(3):310-4. Epub 2010 Jul 13.
357: Ward EM, Schulte PA, Straif K, Hopf NB, Caldwell JC, Carreón T, DeMarini DM, Fowler BA,
Goldstein BD, Hemminki K, Hines CJ, Pursiainen KH, Kuempel E, Lewtas J, Lunn RM, Lynge E,
McElvenny DM, Muhle H, Nakajima T, Robertson LW, Rothman N, Ruder AM, Schubauer-Berigan MK,
Siemiatycki J, Silverman D, Smith MT, Sorahan T, Steenland K, Stevens RG, Vineis P, Zahm SH, Zeise L,
Cogliano VJ. Research recommendations for selected IARC-classified agents. Environ Health Perspect. 2010
Oct;118(10):1355-62. Epub 2010 Jun 18. Review.
356: Rostgaard K, Vaeth M, Rootzén H, Lynge E. Why did the breast cancer lymph node status
distribution improve in Denmark in the pre-mammography screening period of 1978-1994? Acta Oncol.
2010 Apr;49(3):313-21.
355: Lynge E, Rebolj M. Re: Age-specific evaluation of primary human papillomavirus screening vs
conventional cytology in a randomized setting. J Natl Cancer Inst. 2010 May 19;102(10):739; author
reply 739-40. Epub 2010 Apr 1.
354: Rebolj M, Lynge E. Has cytology become obsolete as a primary test in screening for cervical cancer?
J Med Screen. 2010;17(1):1-2.
353: Pallesen PB, Tverborgvik T, Rasmussen HB, Lynge E. Data on education: from population statistics
to epidemiological research. Scand J Public Health. 2010 Mar;38(2):177-83. Epub 2010 Feb 4.
352: Jensen A, Geller BM, Gard CC, Miglioretti DL, Yankaskas B, Carney PA, Rosenberg RD, Vejborg
I, Lynge E. Performance of diagnostic mammography differs in the United States and Denmark. Int J
Cancer. 2010 Oct 15;127(8):1905-12.
351: Rebolj M, Ivanus U, Lynge E. Indicators of quality assurance in cancer screening – the case of
cervical cancer. Bilt-ekon organ inform zdrav 2010;2:44-51.
2009
350: von Euler-Chelpin M, Brasso K, Lynge E. Determinants of participation in colorectal cancer screening
with faecal occult blood testing. J Public Health (Oxf). 2010 Sep;32(3):395-405. Epub 2009 Dec 16.
Review.
349: Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparén P, Tryggvadottir L, Weiderpass
E, Kjaerheim K. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Acta Oncol. 2009;48(5):646-790.
348: Lynge E, Rebolj M. Primary HPV screening for cervical cancer prevention: results from European
trials. Nat Rev Clin Oncol. 2009 Dec;6(12):699-706. Epub 2009 Nov 10. Review.
347: Anttila A, Ronco G; Working Group on the Registration and Monitoring of Cervical Cancer Screening
Programmes in the European Union; within the European Network for Information on Cancer (EUNICE).
Description of the national situation of cervical cancer screening in the member states of the European
Union. Eur J Cancer. 2009 Oct;45(15):2685-708. Epub 2009 Sep 8.
346: Sunde L, Bisgaard ML, Soll-Johanning H, Jacobsen NO, Bolund L, Skouv J, Lynge E. Familial
8
colorectal cancer, can it be identified by microsatellite instability and chromosomal instability? - A casecontrol study. Cancer Biomark. 2009;5(4):197-205.
345: Ronco G, van Ballegooijen M, Becker N, Chil A, Fender M, Giubilato P, Kurtinaitis J, Lancucki L,
Lynge E, Morais A, O'Reilly M, Sparen P, Suteu O, Rebolj M, Veerus P, Zakelj MP, Anttila A. Process
performance of cervical screening programmes in Europe. Eur J Cancer. 2009 Oct;45(15):2659-70. Epub
2009 Aug 25.
344: Johansen K, Bihrmann K, Mikkelsen S, Lynge E. Trends in sickness absence in Denmark. Scand J Work
Environ Health. 2009 Oct;35(5):334-41. Epub 2009 Aug 25.
343: Lynge E, Antilla A, Arbyn M, Segnan N, Ronco G. What's next? Perspectives and future needs of
cervical screening in Europe in the era of molecular testing and vaccination. Eur J Cancer. 2009
Oct;45(15):2714-21. Epub 2009 Aug 18. Review.
342: Elkjaer M, Burisch J, Avnstrøm S, Lynge E, Munkholm P. Development of a Web-based concept
for patients with ulcerative colitis and 5-aminosalicylic acid treatment. Eur J Gastroenterol Hepatol.
2010 Jun;22(6):695-704.
341: Lynge E. From cross-sectional survey to cohort study. Occup Environ Med. 2009 Jul;66(7):428-9.
340: Rebolj M, van Ballegooijen M, Lynge E, Looman C, Essink-Bot ML, Boer R, Habbema D. Incidence
of cervical cancer after several negative smear results by age 50: prospective observational study. BMJ.
2009 Apr 24;338:b1354. doi: 10.1136/bmj.b1354.
339: Olsen AH, Bihrmann K, Jensen MB, Vejborg I, Lynge E. Breast density and outcome of
mammography screening: a cohort study. Br J Cancer. 2009 Apr 7;100(7):1205-8. Epub 2009 Mar 17.
338: Njor SH, Pedersen AT, Schwartz W, Hallas J, Lynge E. Minimizing misclassification of hormone users
at mammography screening. Int J Cancer. 2009 May 1;124(9):2159-65.
337: Lynge E. Mammography screening. In: Schwab M (ed). Encyclopedia of Cancer, 2nd Edition, 2009.
2008
336: Rowland FS, Blake DR, Larsen BR, Lindskog A, Peterson PJ, Williams WP, Wallington TJ, Pilling
MJ, Carslaw N, Creasey DJ, Heard DE, Jacobs P, Lee J, Lewis AC, McQuaid JB, Stockwell WR, Frank H,
Sacco P, Cocheo V, Lynge E, Andersen A, Nilsson R, et al. Abstracts of the 6th FECS Conference 1998
Lectures. Environ Sci Pollut Res Int. 1998;5(3):119-96.
335: Garne JP, Lynge E, Kroman NT, Schwartz W. [Overdiagnosis and overtreatment of breast cancer
2]. Ugeskr Laeger. 2008 Aug 18;170(34):2596; author reply 2596. Danish.
334: Duffy SW, Lynge E, Jonsson H, Ayyaz S, Olsen AH. Complexities in the estimation of overdiagnosis
in breast cancer screening. Br J Cancer. 2008 Oct 7;99(7):1176-8. Epub 2008 Sep 2.
333: Kolte IV, Skinhøj P, Keiding N, Lynge E. The Spanish flu in Denmark. Scand J Infect Dis. 2008;40(67):538-46.
332: Garne JP, Lynge E, Vejborg I, Kroman NT, Schwartz W. [Overdiagnosis and overtreatment of
breast cancer]. Ugeskr Laeger. 2008 Jun 2;170(23):2044; author reply 2045. Danish.
331: Bihrmann K, Jensen A, Olsen AH, Njor S, Schwartz W, Vejborg I, Lynge E. Performance of
systematic and non-systematic ('opportunistic') screening mammography: a comparative study from
9
Denmark. J Med Screen. 2008;15(1):23-6.
330: von Euler-Chelpin M, Olsen AH, Njor S, Jensen A, Vejborg I, Schwartz W, Lynge E. Does
educational level determine screening participation? Eur J Cancer Prev. 2008 Jun;17(3):273-8.
329: Johansen K, Andersen JS, Mikkelsen S, Pass O, Raffnsøe S, Lynge E. Controlling sickness absence:
a study of changes in the Danish sickness absence legislation since 1973. Health Policy. 2008
Apr;86(1):109-18. Epub 2007 Nov 26.
328: Anttila A, Ronco G, Lynge E, Fender M, Arbyn M, Baldauf J-J, Patnick J, McGoogan E, Hakama
M, Miller AB. Epidemilogical guidelines for quality assurance in cervical cancer screening. In: Arbyn M
et al (eds). European Guidelines for Cervic Cancer Screening. Luxembourg: European Commission,
2008.
327: Lynge E. European guidelines for quality assurance in cervical cancer screening – second edition.:
Chapter 2. Epidemiological Guidelines for Quality Assurance in Cervical Cancer Screening.
Luxembourg: European Commision 2008:292.
2007
326: Lynge E, Rostgaard K, Kroman N, Lidegaard Ø, Kvistgaard ME. [Descriptive epidemiology:
Development of incidence over time, geographical and social differences, risk factors, etc]. Ugeskr Laeger.
2007 Sep 3;169(36):2965-7. Danish.
325: von Euler-Chelpin M, Olsen AH, Njor S, Vejborg I, Schwartz W, Lynge E. Sociodemographic determinants of participation in mammography screening. Int J Cancer. 2008 Jan
15;122(2):418-23.
324: von Euler-Chelpin M, Lynge E. Selection of controls. Br J Cancer. 2007 Oct 8;97(7):1019; author reply
1020. Epub 2007 Sep 18.
323: Njor SH, Olsen AH, Schwartz W, Vejborg I, Lynge E. Predicting the risk of a false-positive test
for women following a mammography screening programme. J Med Screen. 2007;14(2):94-7.
322: Ahrens W, Timmer A, Vyberg M, Fletcher T, Guénel P, Merler E, Merletti F, Morales M, Olsson H,
Olsen J, Hardell L, Kaerlev L, Raverdy N, Lynge E. Risk factors for extrahepatic biliary tract carcinoma
in men: medical conditions and lifestyle: results from a European multicentre case-control study. Eur J
Gastroenterol Hepatol. 2007 Aug;19(8):623-30.
321: Lynge E. [Benefits of breast cancer screening]. Ugeskr Laeger. 2007 Apr 16;169(16):1481; author reply
1481. Danish.
320: Olsen AH, Njor SH, Lynge E. Estimating the benefits of mammography screening: the impact of
study design. Epidemiology. 2007 Jul;18(4):487-92.
319: Sundhedsstyrelsen. [Screening for cervical cancer]. Sundheds-styrelsen: København, 2007 [in Danish]
2006
318: Jensen A, Rank F, Dyreborg U, Severinsen N, Nielsen S, Lynge E, Vejborg I. Performance of
combined clinical mammography and needle biopsy: a nationwide study from Denmark. APMIS. 2006
Dec;114(12):884-92.
317: Jensen A, Vejborg I, Lynge E. Brug og diagnostik kvalitet af klinisk mammografi i Danmark – en
medicinsk teknologivurdering. Medicinsk Teknologivurdering 6(12). København; Sundheds-styrelsen,
10
2006.
316: Rostgaard K, Vaeth M, Rootzén H, Mouridsen H, Olesen KP, Lynge E. Do changes in lymph node
status distribution explain trends in survival of breast cancer patients in Denmark? Eur J Cancer Prev. 2006
Oct;15(5):398-404.
315: Törnberg S, Kemetli L, Lynge E, Helene Olsen A, Hofvind S, Wang H, Anttila A, Hakama M, Nyström
L. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography
screening programmes. Acta Oncol. 2006;45(5):528-35.
314: Jacobsen R, Keiding N, Lynge E. Causes of death behind low life expectancy of Danish women. Scand
J Public Health. 2006;34(4):432-6.
313: Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW. Overdiagnosis, sojourn time, and sensitivity in the
Copenhagen mammography screening program. Breast J. 2006 Jul-Aug;12(4):338-42.
312: McLean D, Pearce N, Langseth H, Jäppinen P, Szadkowska-Stanczyk I, Persson B, Wild P, Kishi R,
Lynge E, Henneberger P, Sala M, Teschke K, Kauppinen T, Colin D, Kogevinas M, Boffetta P. Cancer
mortality in workers exposed to organochlorine compounds in the pulp and paper industry: an
international collaborative study. Environ Health Perspect. 2006 Jul;114(7):1007-12.
311: Svendsen AL, Olsen AH, von Euler-Chelpin M, Lynge E. Breast cancer incidence after the
introduction of mammography screening: what should be expected? Cancer. 2006 May 1;106(9):1883-90.
310: Lynge E, Clausen LB, Guignard R, Poll P. What happens when organization of cervical cancer
screening is delayed or stopped? J Med Screen. 2006;13(1):41-6.
309: von Euler-Chelpin M, Olsen AH, Njor S, Vejborg I, Schwartz W, Lynge E. Women's patterns
of participation in mammography screening in Denmark. Eur J Epidemiol. 2006;21(3):203-9.
308: Lynge E, Andersen A, Rylander L, Tinnerberg H, Lindbohm ML, Pukkala E, Romundstad P, Jensen
P, Clausen LB, Johansen K. Cancer in persons working in dry cleaning in the Nordic countries. Environ
Health Perspect. 2006 Feb;114(2):213-9.
307: Jensen A, Vejborg I, Severinsen N, Nielsen S, Rank F, Mikkelsen GJ, Hilden J, Vistisen D, Dyreborg
U, Lynge E. Performance of clinical mammography: a nationwide study from Denmark. Int J Cancer. 2006
Jul 1;119(1):183-91.
306: Puente D, Hartge P, Greiser E, Cantor KP, King WD, González CA, Cordier S, Vineis P, Lynge E,
Chang- Claude J, Porru S, Tzonou A, Jöckel KH, Serra C, Hours M, Lynch CF, Ranft U, Wahrendorf J,
Silverman D, Fernandez F, Boffetta P, Kogevinas M. A pooled analysis of bladder cancer case-control studies
evaluating smoking in men and women. Cancer Causes Control. 2006 Feb;17(1):71-9.
2005
305: Njor SH, Olsen AH, Schwartz W, Lynge E. Tumour size distribution in mammography screening. Breast.
2005 Aug;14(4):329-32.
304: Johansen K, Tinnerberg H, Lynge E. Use of history science methods in exposure assessment
for occupational health studies. Occup Environ Med. 2005 Jul;62(7):434-41.
303: Lutz JM, Cree I, Sabroe S, Kvist TK, Clausen LB, Afonso N, Ahrens W, Ballard TJ, Bell J, Cyr D,
Eriksson M, Févotte J, Guénel P, Hardell L, Jöckel KH, Miranda A, Merletti F, Morales-Suarez-Varela
MM, Stengrevics A, Lynge E. Occupational risks for uveal melanoma results from a case-control study in
11
nine European countries. Cancer Causes Control. 2005 May;16(4):437-47.
302: Stahlberg C, Lynge E, Andersen ZJ, Keiding N, Ottesen B, Rank F, Hundrup YA, Obel EB, Pedersen
AT. Breast cancer incidence, case-fatality and breast cancer mortality in Danish women using hormone
replacement therapy--a prospective observational study. Int J Epidemiol. 2005 Aug;34(4):931-5. Epub 2005
May 24.
301: Jensen A, Mikkelsen GJ, Vestergaard M, Lynge E, Vejborg I. Compliance with European guidelines
for diagnostic mammography in a decentralized health-care setting. Acta Radiol. 2005 Apr;46(2):140-7.
300: Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, Tange UB, Blichert-Toft M, Rank
F, Mouridsen H, Lynge E. A model for determining the effect of mammography service screening. Acta
Oncol. 2005;44(2):120-8.
299: Danø H, Jacobsen R, Hansen KD, Petersen JK, Lynge E. Use of census data for construction of
fertility history for Danish women. Scand J Public Health. 2004;32(6):435-41.
298: Lynge E, Afonso N, Kaerlev L, Olsen J, Sabroe S, Ahrens W, Eriksson M, Guénel P, Merletti F,
Stengrevics A, Suarez-Varela M, Costa-Pererra A, Vyberg M. European multi-centre case-control study
on risk factors for rare cancers of unknown aetiology. Eur J Cancer. 2005 Mar;41(4):601-12. Epub 2005
Jan 26.
297: Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, Tange UB, Blichert-Toft M,
Rank F, Mouridsen H, Lynge E. Breast cancer mortality in Copenhagen after introduction of mammography
screening: cohort study. BMJ. 2005 Jan 29;330(7485):220. Epub 2005 Jan 13.
296: Jensen A, Olsen AH, von Euler-Chelpin M, Helle Njor S, Vejborg I, Lynge E. Do nonattenders
in mammography screening programmes seek mammography elsewhere? Int J Cancer. 2005 Jan
20;113(3):464-70.
2004
295: Njor SH, Olsen AH, Lynge E. [Overdiagnosis or wrong statement method?]. Tidsskr Nor Laegeforen.
2004 Nov 4;124(21):2800; author reply 2800-1. Norwegian.
294: Ingwersen P, Lynge E. [Degree of coverage of Danish health sciences research in the Science Citation
Index, 1998]. Ugeskr Laeger. 2004 Sep 27;166(40):3493-7. Danish.
293: Olsen AH, Njor SH, Lynge E. [Mammography screening without overdiagnosis]. Ugeskr Laeger. 2004
Oct 11;166(42):3737; author reply 3737-8.
292: Guénel P, Cyr D, Sabroe S, Lynge E, Merletti F, Ahrens W, Baumgardt-Elms C, Ménégoz F, Olsson
H, Paulsen S, Simonato L, Wingren G. Alcohol drinking may increase risk of breast cancer in men: a
European population-based case-control study. Cancer Causes Control. 2004 Aug;15(6):571-80.
291: Stahlberg C, Pedersen AT, Andersen ZJ, Keiding N, Hundrup YA, Obel EB, Møller S, Rank F, Ottesen
B, Lynge E. Breast cancer with different prognostic characteristics developing in Danish women using
hormone replacement therapy. Br J Cancer. 2004 Aug 16;91(4):644-50.
290: Danø H, Hansen KD, Jensen P, Petersen JH, Jacobsen R, Ewertz M, Lynge E. Fertility pattern does
not explain social gradient in breast cancer in denmark. Int J Cancer. 2004 Sep 1;111(3):451-6.
289: Kaerlev L, Lynge E, Sabroe S, Olsen J. Colon cancer controls versus population controls in casecontrol studies of occupational risk factors. BMC Cancer. 2004 Apr 22;4:15.
12
288: Jacobsen R, Von Euler M, Osler M, Lynge E, Keiding N. Women's death in Scandinavia--what makes
Denmark different? Eur J Epidemiol. 2004;19(2):117-21.
287: Stahlberg C, Pedersen AT, Lynge E, Andersen ZJ, Keiding N, Hundrup YA, Obel EB, Ottesen B.
Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used
in Europe. Int J Cancer. 2004 May 1;109(5):721-7.
286: Sancho-Garnier H, Levi F, Pisani P, Lynge E. Europe’s cancer burden. In: Sancho-Garnier H. Anderson
A, Biedermann A, Lynge E, Slama K (eds). Evidence-based cancer prevention: Strategies for NGOs. Geneva:
UICC International Union Against Cancer, 2004.
285: Lynge E. Social inequalities in cancer. In: Sancho-Garnier H. Anderson A, Biedermann A, Lynge E,
Slama K (eds). Evidence-based cancer prevention: Strategies for NGOs. Geneva: UICC International
Union Against Cancer, 2004.
284: Aapro MS, Aaro LE, Aro AR, Bergenmar M, Bloch J, Borras Andres M, Bottomley A, Burg J, Corner J,
Evered D, Flechtner H, Geyer S, Greimel E, Hine D, Johansen C, Klepp KI, Lynge E, Marteau T, Paltrinieri
B, Poetschke-Langer M, Rautalahti M, Razavi D, Sasco AJ, Segnan N, Straif K, Vertio H, De Vries H.
Research in the behavioural and social sciences to improve cancer control and care: A strategy for
development. A report of an Expert Group. Eur J Cancer 2004;40:316-25.
2003
283: Kogevinas M, 't Mannetje A, Cordier S, Ranft U, González CA, Vineis P, Chang-Claude J, Lynge E,
Wahrendorf J, Tzonou A, Jöckel KH, Serra C, Porru S, Hours M, Greiser E, Boffetta P. Occupation and
bladder cancer among men in Western Europe. Cancer Causes Control. 2003 Dec;14(10):907-14.
282: Kaerlev L, Lynge E, Sabroe S, Olsen J. Reliability of data from next-of-kin: results from a casecontrol study of occupational and lifestyle risk factors for cancer. Am J Ind Med. 2003 Sep;44(3):298303.
281: Arbyn M, Van Oyen H, Lynge E, Micksche M, Faivre J, Jordan J. European Commission's proposal
for a council recommendation on cancer screening. BMJ. 2003 Aug 2;327(7409):289-90.
280: Ronco G, Montanari G, Confortini M, Parisio F, Berardengo E, Delpiano AM, Arnaud S, Campione
D, Baldini D, Poll P, Lynge E, Mancini E, Segnan N. Effect of circulation and discussion of cervical
smears on agreement between laboratories. Cytopathology. 2003 Jun;14(3):115-20.
279: Stahlberg C, Pederson AT, Lynge E, Ottesen B. Hormone replacement therapy and risk of breast cancer:
the role of progestins. Acta Obstet Gynecol Scand. 2003 Jul;82(7):335-44. Review.
278: Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of
mammography screening in Europe. Eur J Cancer Prev. 2003 Jun;12(3):213-22. Review.
277: Njor SH, Olsen AH, Bellstrøm T, Dyreborg U, Bak M, Axelsson C, Graversen HP, Schwartz W,
Lynge E. Mammography screening in the county of Fyn. November 1993-December 1999. APMIS
Suppl. 2003;(110):1-33.
276: Stahlberg C, Pedersen AT, Lynge E, Ottesen B. Hormone replacement therapy and risk of breast cancer:
the role of progestins. Acta Obstet Gynecol Scand. 2003 Apr;82(4):335-44. Review. Corrected and
republished in: Acta Obstet Gynecol Scand. 2003 Jul;82(7):335-44.
275: Danø H, Andersen O, Ewertz M, Petersen JH, Lynge E. Socioeconomic status and breast cancer in
Denmark. Int J Epidemiol. 2003 Apr;32(2):218-24.
13
274: Olsen AH, Jensen A, Njor SH, Villadsen E, Schwartz W, Vejborg I, Lynge E. Breast cancer
incidence after the start of mammography screening in Denmark. Br J Cancer. 2003 Feb 10;88(3):362-5.
2002
273: Tange UB, Jensen MB, Vejborg IM, Rank FE, Blichert-Toft M, Mouridsen HT, Lynge E. Clinical
impact of introduction of mammography screening in a non-screening country with special reference to the
Copenhagen service mammography screening programme. Scand J Surg. 2002;91(3):293-303. Review.
272: Vejborg I, Olsen AH, Jensen MB, Rank F, Tange UB, Lynge E. Early outcome of
mammography screening in Copenhagen 1991-99. J Med Screen. 2002;9(3):115-9.
271: Lynge E. Prostate cancer is not increased in men with vasectomy in denmark. J Urol. 2002
Aug;168(2):488-90.
270: Lynge E. [Screening for cancer. International knowledge and Danish practice]. Ugeskr Laeger. 2002
May 27;164(22):2892-7. Review. Danish.
269: Tange UB, Hirsch FR, Jensen MB, Olsen AH, Blichert-Toft M, Rank FE, Vejborg IM, Mouridsen H,
Lynge E. [Mammography screening in the county of Copenhagen. Results of the first three screening
rounds]. Ugeskr Laeger. 2002 Feb 18;164(8):1048-52. Danish.
268: Tange UB, Hirsch FR, Jensen MB, Olsen AH, Blichert-Toft M, Rank FE, Vejborg IM, Mouridsen
H, Lynge E. [Mammographic screening in the county of Copenhagen. Clinical consequences of the first
three screening rounds]. Ugeskr Laeger. 2002 Feb 18;164(8):1036-40. Danish.
267: Jacobsen R, Keiding N, Lynge E. Long term mortality trends behind low life expectancy of
Danish women. J Epidemiol Community Health. 2002 Mar;56(3):205-8.
266: Christensen LB, Rank FE, Blichert-Toft M, Christiansen T, Jørgensen T, Dunn S, Jensen LB, Vejborg
IM, Tange UB, Mouridsen H, Lynge E. [Mammographic screening in the municipality of Copenhagen 19911997. Evaluation of the preoperative assessment]. Ugeskr Laeger. 2002 Jan 7;164(2):191-5. Danish.
265: Lynge E. [Recommendations on cancer screening in the European Union. Advisory Committee on
Cancer Prevention]. Ugeskr Laeger. 2002 Jan 7;164(2):176-8. Danish.
264: Lynge E. [Cervical cancer screening]. Ugeskr Laeger. 2002 Jan 7;164(2):171-3. Danish.
2001
263: Rostgaard K, Mouridsen HT, Vaeth M, Holst H, Olesen KP, Lynge E. A modified Nottingham
prognostic index for breast cancer patients diagnosed in Denmark 1978-1994. Acta Oncol. 2001;40(7):838-43.
262: Arbyn M, Van Oyen H, Lynge E, Mickshe M. European consensus on cancer screening should
be applied urgently by health ministers. BMJ. 2001 Aug 18;323(7309):396.
261: Guénel P, Laforest L, Cyr D, Févotte J, Sabroe S, Dufour C, Lutz JM, Lynge E. Occupational risk
factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes Control.
2001 Jun;12(5):451-9.
260: Lynge E. Commentary: cancer in the air. Int J Epidemiol. 2001 Aug;30(4):830-2.
259: Micksche M, Lynge E, Diehl V, Estape J, Vertio H, Faivre J, Papamichail M, Daly PA, Veronesi U,
Dicato M, Kroes R, Limbert E, Holm LE, Vandenbroucke A, Davies T; Groupe des Experts Cancérologues
de l'Union Européenne. [Recommendations on cancer screening in the European Union]. Bull Cancer. 2001
14
Jul;88(7):687-92. French.
258: Jacobsen R, Jensen A, Keiding N, Lynge E. Queen Margrethe II and mortality in Denmark. Lancet. 2001
Jul 7;358(9275):75.
257: Rostgaard K, Vaeth M, Holst H, Madsen M, Lynge E. Age-period-cohort modelling of breast
cancer incidence in the Nordic countries. Stat Med. 2001 Jan 15;20(1):47-61.
256: Lynge E. [Mammography. Screening or not]. Ugeskr Laeger. 2001 Jan 8;163(2):137. Danish.
255: Lynge E. Cancer Screening. In: Souhami RL, Tannock I, Hochenberger P, Horiot J-C (eds.) Oxford
Textbook of Oncology, Second Edition. Oxford: Oxford University Press, 2001, p 215 - 23.
254: Lynge E, Micksche M. Response to Comments on: Recommendations on colorectal cancer (CRC)
screening in the European Union. Advisory Committee on cancer Prevention. Eur J Cancer 2001;37:440.
253: Sankila R, Lynge E. Screening for breast cancer: cohort studies In: Sankila R, Démaret E, Hakama
M, Lynge E, Schouten L, Parkin DM (eds.): Evaluation and Monitoring of screening Programmes.
Bruxelles- Luxembourg: European Commission, 2001,p 163-81.
252: Lynge E. Cohort studies in evaluation of cervical cancer screening. In: Sankila R, Démaret E, Hakama
M, Lynge E, Schouten L, Parkin DM (eds.): Evaluation and Monitoring of screening Programmes. BruxellesLuxembourg: European Commission, 2001 p. 119-31.
2000
251: Sala M, Cordier S, Chang-Claude J, Donato F, Escolar-Pujolar A, Fernandez F, González CA, Greiser E,
Jöckel KH, Lynge E, Mannetje A, Pohlabeln H, Porru S, Serra C, Tzonou A, Vineis P, Wahrendorf J,
Boffetta P, Kogevina M. Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of casecontrol studies in European countries. Cancer Causes Control. 2000 Dec;11(10):925-31.
250: Bigaard J, Hariri J, Lynge E. Cervical cancer screening in Denmark. Eur J Cancer. 2000
Nov;36(17):2198-204.
249: van Ballegooijen M, van den Akker-van Marle E, Patnick J, Lynge E, Arbyn M, Anttila A, Ronco G,
Dik J, Habbema F. Overview of important cervical cancer screening process values in European Union (EU)
countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer.
2000 Nov;36(17):2177-88.
248: Rostgaard K, Holst H, Mouridsen HT, Lynge E. Do clinical databases render population-based
cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control. 2000
Aug;11(7):669-74.
247: Døssing M, Lynge E. [Screening for lung cancer]. Ugeskr Laeger. 2000 Aug 7;162(32):4282. Danish.
246: Døssing M, Lynge E. [Screening for lung cancer--are we to use resources for that?]. Ugeskr Laeger.
2000 Jun 26;162(26):3736-7. Danish.
245: Advisory Committee on Cancer Prevention. Recommendations on cancer screening in the European
Union. Eur J Cancer 2000;36:1473-8
1999
244: Andersen A, Barlow L, Engeland A, Kjaerheim K, Lynge E, Pukkala E. Work-related cancer in the
Nordic countries. Scand J Work Environ Health. 1999;25 Suppl 2:1-116. Review.
243: Mannetje A, Kogevinas M, Chang-Claude J, Cordier S, González CA, Hours M, Jöckel KH,
15
Bolm- Audorff U, Lynge E, Porru S, Donato F, Ranft U, Serra C, Tzonou A, Vineis P, Wahrendorf J,
Boffetta P. Occupation and bladder cancer in European women. Cancer Causes Control. 1999
Jun;10(3):209-17.
242: Lynge E. Mortality of workers exposed to methylene chloride employed at a plant producing
cellulose triacetate film base. Occup Environ Med. 1999 Mar;56(3):215.
241: 't Mannetje A, Kogevinas M, Chang-Claude J, Cordier S, González CA, Hours M, Jöckel KH, BolmAudorff U, Lynge E, Porru S, Donato F, Ranft U, Serra C, Tzonou A, Vineis P, Wahrendorf J, Boffetta P.
Smoking as a confounder in case-control studies of occupational bladder cancer in women. Am J Ind Med.
1999 Jul;36(1):75-82.
240: Fortuny J, Kogevinas M, Chang-Claude J, González CA, Hours M, Jöckel KH, Bolm-Audorff U, Lynge
E, 't Mannetje A, Porru S, Ranft U, Serra C, Tzonou A, Wahrendorf J, Boffetta P. Tobacco, occupation and
non- transitional-cell carcinoma of the bladder: an international case-control study. Int J Cancer. 1999 Jan
5;80(1):44-6.
1998
239: Boffetta P, Sali D, Kolstad H, Coggon D, Olsen J, Andersen A, Spence A, Pesatori AC, Lynge E,
Frentzel- Beyme R, Chang-Claude J, Lundberg I, Biocca M, Gennaro V, Teppo L, Partanen T, Welp E,
Saracci R, Kogevinas M. Mortality of short-term workers in two international cohorts. J Occup Environ Med.
1998 Dec;40(12):1120-6.
238: Lynge E. Mammography screening for breast cancer in Copenhagen April 1991-March
1997. Mammography Screening Evaluation Group. APMIS Suppl. 1998;83:1-44.
237: Lynge E. Cancer incidence in Danish phenoxy herbicide workers, 1947-1993. Environ Health Perspect.
1998 Apr;106 Suppl 2:683-8.
236: Vena J, Boffetta P, Becher H, Benn T, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D,
Green L, Kauppinen T, Littorin M, Lynge E, Mathews JD, Neuberger M, Pearce N, Pesatori AC, Saracci
R, Steenland K, Kogevinas M. Exposure to dioxin and nonneoplastic mortality in the expanded IARC
international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers.
Environ Health Perspect. 1998 Apr;106 Suppl 2:645-53.
235: Raffn E, Villadsen E, Engholm G, Lynge E. [Lung cancer among asbestos-cement workers in
Denmark]. Ugeskr Laeger. 1998 Feb 9;160(7):1029-33. Danish.
234: Rix BA, Villadsen E, Lynge E. Cancer incidence of sulfite pulp workers in Denmark. Scand J Work
Environ Health. 1997 Dec;23(6):458-61.
233: Johansen C, Schou G, Soll-Johanning H, Mellemgaard A, Lynge E. [Marital status and survival
in colorectal cancer]. Ugeskr Laeger. 1998 Jan 26;160(5):635-8. Danish.
232: Engholm G, Palmgren F, Lynge E. [Lung cancer, tobacco smoking and environmental factors in
Denmark]. Ugeskr Laeger. 1998 Jan 26;160(5):626-31. Danish.
231: Rix BA, Villadsen E, Engholm G, Lynge E. Hodgkin's disease, pharyngeal cancer, and soft
tissue sarcomas in Danish paper mill workers. J Occup Environ Med. 1998 Jan;40(1):55-62.
230: Lynge E. Cervical cancer screening in Denmark. Can cervical cancer screening be cost-effective? In:
Ottesen B, Tabor A (eds). New Insights in Gynecology and Obstetrics. Lancs: Parthenon Publishing 1998; pp.
251-6.
16
229: Lynge E. Occupational mortality. In: Armitage P, Colton T (eds). Encyclopedia of Biostatistics.
Sutton: John Wiley Ltd, 1998; pp. 3151-7.
1997
228: Rix BA, Villadsen E, Engholm G, Lynge E. Risk of cancer among paper recycling workers. Occup
Environ Med. 1997 Oct;54(10):729-33.
227: Kogevinas M, Becher H, Benn T, Bertazzi PA, Boffetta P, Bueno-de-Mesquita HB, Coggon D, Colin
D, Flesch-Janys D, Fingerhut M, Green L, Kauppinen T, Littorin M, Lynge E, Mathews JD, Neuberger M,
Pearce N, Saracci R. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and
dioxins. An expanded and updated international cohort study. Am J Epidemiol. 1997 Jun 15;145(12):106175.
226: Lynge E, Anttila A, Hemminki K. Organic solvents and cancer. Cancer Causes Control. 1997
May;8(3):406-19. Review.
225: Rix BA, Lynge E. Soft tissue sarcomas among female paper sorters in Denmark. Cancer Causes Control.
1997 Mar;8(2):259.
224: Lynge E, Andersen A, Nilsson R, Barlow L, Pukkala E, Nordlinder R, Boffetta P, Grandjean P,
Heikkilä P, Hörte LG, Jakobsson R, Lundberg I, Moen B, Partanen T, Riise T. Risk of cancer and exposure
to gasoline vapors. Am J Epidemiol. 1997 Mar 1;145(5):449-58.
223: Lynge E, Andersen O. Unemployment and cancer in Denmark, 1970-1975 and 1986-1990. IARC Sci
Publ. 1997;(138):353-9.
222: Lynge E. Unemployment and cancer: a literature review. IARC Sci Publ. 1997;(138):343-51. Review.
221: Bos AB, van Ballegooijen M, van Oortmarssen GJ, van Marle ME, Habbema JD, Lynge E.
Non- progression of cervical intraepithelial neoplasia estimated from population-screening data. Br J
Cancer. 1997;75(1):124-30.
220: Lynge E. Screening mod livmoderhalskræft Bornholms amtskommune 1987-90 og 1991-93.
København, Kræftens Bekæmpelse, 1997.
219: Sundhedsstyrelsens Følgegruppe vedr. brystkræft. Statusrapport. Sundhedsstyrelsen, København, 1997.
218: Rix BA, Skov T, Lynge E. Socioeconomic group, occupation and incidence of breast cancer and
genital cancer among women in Denmark. Eur J Public Health 1997;7:177-81.
217: Lynge E, Villadsen E, Raffn E, Engholm G. Lung cancer in asbestos cement workers in Denmark.
(Letter). Occup Environ Med 1997;54:143.
1996
216: Tüchsen F, Jensen MV, Villadsen E, Lynge E. Incidence of lung cancer among cobalt-exposed
women. Scand J Work Environ Health. 1996 Dec;22(6):444-50.
215: Carstensen B, Soll-Johanning H, Villadsen E, Søndergaard JO, Lynge E. Familial aggregation
of colorectal cancer in the general population. Int J Cancer. 1996 Nov 15;68(4):428-35.
214: Welp E, Kogevinas M, Andersen A, Bellander T, Biocca M, Coggon D, Esteve J, Gennaro V, Kolstad
H, Lundberg I, Lynge E, Partanen T, Spence A, Boffetta P, Ferro G, Saracci R. Exposure to styrene and
mortality from nervous system diseases and mental disorders. Am J Epidemiol. 1996 Oct 1;144(7):623-33.
17
213: Raffn E, Villadsen E, Lynge E. Colorectal cancer in asbestos cement workers in Denmark. Am J Ind
Med. 1996 Sep;30(3):267-72.
212: Johansen C, Schou G, Soll-Johanning H, Mellemgaard A, Lynge E. Influence of marital status on
survival from colon and rectal cancer in Denmark. Br J Cancer. 1996 Sep;74(6):985-8. Erratum in: Br J
Cancer 1997;76(9):1253.
211: Lynge E, Arffmann E, Behnfeld L, Byrjalsen C, Glenthøj A, Hølund B, Knudsen ES, Lehmann
Knudsen J, Olesen F, Poll PA, Rasmussen BB, Rasmussen J, Sonne A, Otoft E. [Preventive examinations
for cervix cancer in Denmark. Status in 1995. Plans for 1996]. Ugeskr Laeger. 1996 Aug 26;158(35):49169. Danish.
210: Rix BA, Lynge E. Industrial hygiene measurements in a new industry: the repulping and deinking of
paper waste. Am J Ind Med. 1996 Aug;30(2):142-7.
209: Welp E, Partanen T, Kogevinas M, Andersen A, Bellander T, Biocca M, Coggon D, Gennaro V,
Kolstad H, Lundberg I, Lynge E, Spence A, Ferro G, Saracci R, Boffetta P. Exposure to styrene and
mortality from nonmalignant respiratory diseases. Occup Environ Med. 1996 Jul;53(7):499-501.
208: Welp E, Partanen T, Kogevinas M, Andersen A, Bellander T, Biocca M, Coggon D, Fontana V, Kolstad
H, Lundberg I, Lynge E, Spence A, Ferro G, Boffetta P, Saracci R. Exposure to styrene and mortality from
nonmalignant diseases of the genitourinary system. Scand J Work Environ Health. 1996 Jun;22(3):223-6.
207: Rix BA, Lynge E. Cancer incidence in Danish health care workers. Scand J Soc Med. 1996
Jun;24(2):114-20.
206: Raffn E, Villadsen E, Engholm G, Lynge E. Lung cancer in asbestos cement workers in Denmark. Occup
Environ Med. 1996 Jun;53(6):399-402.
205: Engholm G, Palmgren F, Lynge E. Lung cancer, smoking, and environment: a cohort study of the
Danish population. BMJ. 1996 May 18;312(7041):1259-63.
204: Lynge E. Use of cancer incidence data in identification of cancer causation. Environ Health Perspect.
1996 May;104 Suppl 3:639-41. Review.
203: Kolstad HA, Pedersen B, Olsen J, Lynge E, Jensen G, Lisse I, Philip P, Pedersen NT. Clonal
chromosome aberrations in myeloid leukemia after styrene exposure. Scand J Work Environ Health. 1996
Feb;22(1):58-61.
202: Danø H, Skov T, Lynge E. Underreporting of occupational cancers in Denmark. Scand J Work
EnvironHealth. 1996 Feb;22(1):55-7.
201: Lynge E. Risk of breast cancer is also increased among Danish female airline cabin attendants. BMJ.
1996 Jan 27;312(7025):253.
200: Lynge E. Breast cancer screening. The scientific basis and the Danish programme. In: Calvo F, Crepin
M, Magdelenat H (eds). Breast Cancer. Advances in biology and therapeutics. John Libbey Eurotext,
Montrouge
1996: pp. 67-71.
1995
199: Lynge E, Rix BA, Villadsen E, Andersen I, Hink M, Olsen E, Møller UL, Silfverberg E. Cancer
in printing workers in Denmark. Occup Environ Med. 1995 Nov;52(11):738-44.
198: Vineis P, Cantor K, Gonzales C, Lynge E, Vallyathan V. Occupational cancer in developed
18
and developing countries. Int J Cancer. 1995 Sep 15;62(6):655-60. Review.
197: Lynge E, Carstensen B, Andersen O. Primary liver cancer and renal cell carcinoma in laundry and
dry- cleaning workers in Denmark. Scand J Work Environ Health. 1995 Aug;21(4):293-5.
196: Kolstad HA, Juel K, Olsen J, Lynge E. Exposure to styrene and chronic health effects: mortality
and incidence of solid cancers in the Danish reinforced plastics industry. Occup Environ Med. 1995
May;52(5):320-7.
195: Lynge E. New draft on European directive on confidential data. BMJ. 1995 Apr 22;310(6986):1024.
194: Juel K, Lynge E. Dødelighed og kræftforekomst blandt ansatte på Cheminova Agro. Dansk Institut for
Klinisk Epidemiologi, Kræftens Bekæmpelse, København, 1995.
193: Lynge E. A book review. Doll R, Fraumeni Jr. JF, Muir CS (eds). Trends in cancer incidence
and mortality. New York: Cold Spring Habor Press, 1994. Scand J Work Environ Health
1995;21:236.
192: Kogevinas M, Kauppinen T, Winkelmann R, Becher H, Bertazzi PA, de Mesquita BHB, Coggon D,
Green L, Johnson E, Littorin M, Lynge E, Marlow DA, Mathews JD, Neuberger M, Benn T, Pannett B,
Pearce N, Saracci R. Soft-tissue sarcoma and non-Hodgkin's lymphoma in workers exposed to phenoxy
herbicides, chlorophenols and dioxins. Two nested case-control studies. Epidemiology 1995;6:396-402.
191: Lynge E. Epidemiologisk forskning og datasikkerhed - ny positiv vending i forhandlingerne om et
EU- direktiv. Ugeskrift for Læger 1995;157:3222-3.
190: Lynge E, Bøggild P, Ebbensgaard K, Hansen KS, Heebøll-Nielsen NC, Hvolris M, Jensen KV,
Kristensen K, Meyer G, Petersen KF, Røpke I, Schmidt L-H, Thorn NA, Hansen PO, Worm M. Osteoporosis.
København: Dansk Sygehus Institut, 1995.
1994
189: Lynge E. Danish Cancer Registry as a resource for occupational research. J Occup Med. 1994.
Nov;36(11):1169-73.
188: Andreasen AH, Andersen KW, Madsen M, Mouridsen HT, Olesen KP, Lynge E.
[Mammographic examinations in Denmark, 1990-1991]. Ugeskr Laeger. 1994 Oct 31;156(44):651720. Danish.
187: Andreasen AH, Mouridsen HT, Andersen KW, Lynge E, Madsen M, Olesen KP. [Improved prognosis
of breast cancer]. Ugeskr Laeger. 1994 Oct 31;156(44):6512-7. Danish.
186: Johansen C, Mellemgaard A, Skov TB, Kjaergaard J, Lynge E. [Colorectal cancer in Denmark 19431988]. Ugeskr Laeger. 1994 Oct 3;156(40):5840-3. Danish.
185: Kolstad HA, Lynge E, Olsen J, Breum N. Incidence of lymphohematopoietic malignancies among
styrene- exposed workers of the reinforced plastics industry. Scand J Work Environ Health. 1994
Aug;20(4):272-8.
184: Møller H, Knudsen LB, Lynge E. Risk of testicular cancer after vasectomy: cohort study of over
73,000 men. BMJ. 1994 Jul 30;309(6950):295-9.
183: Andreasen AH, Andersen KW, Madsen M, Mouridsen H, Olesen KP, Lynge E. Regional trends in
breast cancer incidence and mortality in Denmark prior to mammographic screening. Br J Cancer. 1994
Jul;70(1):133-7.
19
182: Lynge E, Arffmann E, Poll P, Andersen PK. [Consequences of incorrect interpretation of vaginal
smear tests in a screening program]. Ugeskr Laeger. 1994 Apr 25;156(17):2594-6. Danish.
181: Lynge E, Philip J. [European guidelines for quality assurance in the screening for cancer of the
uterine cervix]. Ugeskr Laeger. 1994 Mar 14;156(11):1654. Danish.
180: Lynge E. European directive on confidential data: a threat to epidemiology. BMJ. 1994 Feb
19;308(6927):490.
179: Lynge E, Arffmann E, Erbs K, Hansen KC, Henriksen B, Holten IW, Hølund B, Jakobsen AB,
Jespersen NB, Olesen F, et al. [Status of preventive screening for uterine cervix cancer in Denmark in
1994]. Ugeskr Laeger. 1994 Jan 24;156(4):471-3. Danish.
178: Boffetta P, Andersen A, Lynge E, Barlow L, Pukkala E. Employment as hairdresser and risk of
ovarian cancer and non-Hodgkin's lymphomas among women. J Occup Med. 1994 Jan;36(1):61-5.
177: Skov T, Lynge E. Cancer risk and exposures to carcinogens in hairdressers. Skin Pharmacol. 1994;7(12):94-100.
176: Andreasen AH, Mouridsen HT, Andersen KW, Lynge E, Madsen M, Olesen KP. Equity and
improvement in outcome of breast cancer in Denmark. Stud Health Technol Inform. 1994;14:27-38.
175: Lynge E, Carstensen B, Vang A. Screening mod livmoderhals-kræft i Københavns Kommune i perioden
1.7.1987-31.12.1990 og perioden 1.1.1991-31.12.1993. København: Københavns Sundhedsvæsen.
Direktoratet, 1994.
174: Lynge E, Knudsen LB, Møller H. Vasectomy and testis and prostate cancer. Fertil Control Rev 1994;3:813.
173: Philip J, Lynge E, Coleman D, Day N, Douglas G, Farmery E, Segnan N. Europe against cancer;
European guidelines for cervical cancer screening. In: Popkin DR, Peedle LJ, (eds). Impact of cervical cancer.
Section 8. Montreal: Proceedings of the XIV World Congress of Gynecology and Obstetrics, 1994.
172: Kogevinas M, Ferro G, Andersen A, Bellander T, Biocca M, Coggon D, Gennaro V, Hutchings S,
Kolstad H, Lundberg I, Lynge E, Partanen T, Saracci R. Cancer mortality in a historical cohort study of
workers exposed to styrene. Scand J Work Environ Health 1994;20:251-61.
171: Sundhedsstyrelsens udvalg vedrørende tidlig opsporing og undersøgelse af lidelser i brystet.
Brystkræft. Tidlig opsporing og undersøgelse. Redegørelse. København: Sundhedsstyrelsen, 1994.
170: Aldaz DMA, Aupee M, Batal-Steil S, Cecchini S, Chamberlain J, Ciatto S, Elizaga A, Gairard B,
Grazzini G, Guldenfels C, Herity B, Kosmidis PA, Lynge E, Paci E, Renaud R, Robra BP, Rodrigues VL,
Sancho- Garnier H, Schaffer P, da Silva DP, Tubiana M, Rosselli del Turco M, van Veen WA,
Vandenbroucke A. Cancer screening in the European Union. Eur J Cancer 1994;30:860-72.
169: Holm N, Lynge E, Rørth M, Specht L, Sælan H, Østerlind K. Kræftudvikling og
kræftdødelighed. Middellevetidsudvalget. København: Sundhedsministeriet 1994.
1993
168: de Fine Olivarius F, Worm AM, Petersen CS, Kroon S, Lynge E. [Effect of a safe-sex campaign
on women attending a clinic of venereology. Sex behavior and prevalence of sexually transmitted
diseases in women examined at the Venereaklinik in Copenhagen in 1984 and 1988]. Ugeskr Laeger.
1993 Nov 15;155(46):3773-6. Danish.
20
167: Kogevinas M, Saracci R, Winkelmann R, Johnson ES, Bertazzi PA, Bueno de Mesquita BH, Kauppinen
T, Littorin M, Lynge E, Neuberger M, et al. Cancer incidence and mortality in women occupationally exposed
to chlorophenoxy herbicides, chlorophenols, and dioxins. Cancer Causes Control. 1993 Nov;4(6):547-53.
166: Kjaer SK, Engholm G, Dahl C, Bock JE, Lynge E, Jensen OM. Case-control study of risk factors for
cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use. Cancer Causes Control.
1993 Nov;4(6):513-9.
165: Guénel P, Raskmark P, Andersen JB, Lynge E. Incidence of cancer in persons with occupational
exposure to electromagnetic fields in Denmark. Br J Ind Med. 1993 Aug;50(8):758-64.
164: Lynge E, Arffmann E, Poll P, Anderson PK. Smear misclassification in a cervical cancer
screening programme. Br J Cancer. 1993 Aug;68(2):368-73.
163: Kristensen TS, Lynge E. Lung cancer among butchers and slaughterhouse workers. Scand J Work
Environ Health. 1993 Jun;19(3):137-47. Review.
162: Kauppinen T, Kogevinas M, Johnson E, Becher H, Bertazzi PA, Bueno de Mesquita HB, Coggon
D, Green L, Littorin M, Lynge E, et al. Chemical exposure in manufacture of phenoxy herbicides and
chlorophenols and in spraying of phenoxy herbicides. Am J Ind Med. 1993 Jun;23(6):903-20. Review.
161: Skov T, Weiner J, Pukkala E, Malker H, Andersen A, Lynge E. Risk for cancer of the pharynx and
oral cavity among male painters in the Nordic countries. Arch Environ Health. 1993 May-Jun;48(3):17680.
160: Lynge E. Cancer in phenoxy herbicide manufacturing workers in Denmark, 1947-87--an update. Cancer
Causes Control. 1993 May;4(3):261-72. Review.
159: Johansen C, Mellemgaard A, Skov T, Kjaergaard J, Lynge E. Colorectal cancer in Denmark 19431988. Int J Colorectal Dis. 1993 Mar;8(1):42-7.
158: Johansen C, Soll-Johanning H, Kolstad H, Lynge E, Carstensen B. Survival of Danish cancer patients
1943-1987. Digestive organs. APMIS Suppl. 1993;33:35-76.
157: Lynge E, Knudsen LB, Møller H. Vasectomy and testicular cancer: epidemiological evidence
of association. Eur J Cancer. 1993;29A(7):1064-6.
156: Coleman D, Day N, Douglas G, Farmery E, Lynge E, Philip J, Segnan N. European Guidelines for
Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. Eur J Cancer. 1993;29A
Suppl 4:S1-38.
155: Kolstad HA, Lynge E, Olsen J. Cancer incidence in the Danish reinforced plastics industry. IARC Sci
Publ. 1993;(127):301-8.
154: Lynge E. Implication for epidemiology of disease registers. Public Health Rev. 1993-1994;21(3-4):26370. Review.
153: Arbejdsgruppen vedrørende registerforskning. Styrkelse af dansk registerforskning. Beretning fra
en arbejdsgruppe. København. Danmarks Grundforskningsfond, 1993.
152: Kogevinas M, Ferro G, Saracci R, Andersen A, Biocca M, Coggon D, Gennaro V, Hutchings S, Kolstad
H, Lundberg I, Lynge E, Partanen T. Cancer mortality in an international cohort of workers exposed to
styrene. In: Sorsa M, Peltonen K, Vainio H, Hemminki K (eds). Butadiene and Styrene: Assessment of
Health Hazards. IARC Scientific Publications No. 127, Lyon 1993:289-300.
21
151: Saracci R, Simonato L, Bulbuljan M, Lynge E, Gardner M, Pylev L. Epidemiological aspects of
cancer risk associated with exposure in the occupational environment. In: Bodmer W, Zaridze D. eds.
International Meeting All-Union Cancer Research Centre in Moscow, USSR, 2-4 September 1991. Cancer
prevention in Europe. Organization of European Cancer Institutes. Geneva, 1993.
150: Kjær SK, de Villiers E-M, Caglayan H, Svare E, Haugaard BJ, Engholm G, Christensen RB, Møller
KA, Poll P, Jensen H, Vestergaard BF, Lynge E, Jensen OM. Human papillomavirus, herpes simplex virus
and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area
(Denmark) – a second look. Br J Cancer 1993;67:830-7.
149: Andersen O, Autrup H, Dayan AD, Fenger J, Forslund J, Grandjean P, Grøn P, Jensen FP, Keiding
L, Kjærgaard S, Larsen JC, Lewtas J, Lynge E, Møller H, Möller L, Nielsen PA, Ostenfeldt N, Pilsgaard
H, Portier C, Poulsen E, Rastogi SC, Skov T, Thomsen AS, Ulbak K, Østerlind A. Report from the
working group on cancer and the non-occupational environment. Pharmacol and Toxicol 1993:72(Suppl
1):167-71.
148: Skov T, Hermind B, Lynge E. Legislation by the European Community on carcinogens. Pharmacol
Toxicol. 1993;72 Suppl 1:155-60. Review.
147: Raffn E, Lynge E, Korsgaard B. Incidence of lung cancer by histological type among asbestos
cement workers in Denmark. Br J Ind Med. 1993 Jan;50(1):85-9.
146: Lynge E, Poll P, Larsen J, Schultz HB, Thommesen N. [Frequency and follow-up of non-negative
cervical smears in the counties of Storstrøm, Vestsjaelland and Bornholm in 1979-1989]. Ugeskr Laeger.
1993 Jan 25;155(4):240-5. Danish.
1992
145: Kogevinas M, Saracci R, Bertazzi PA, Bueno de Mesquita BH, Coggon D, Green LM, Kauppinen T,
Littorin M, Lynge E, Mathews JD, Neuberger M, Osman J, Pearce N, Winkelmann R. Cancer mortality from
soft-tissue sarcoma and malignant lymphomas in an International cohort of workers exposed to
chlorophenoxy herbicides and chlorophenols. Chemosphere 1992;25:1071-6.
144: Skov T, Maarup B, Olsen J, Rørth M, Winthereik H, Lynge E. Leukaemia and reproductive
outcome among nurses handling antineoplastic drugs. Br J Ind Med. 1992 Dec;49(12):855-61.
143: Lynge E. The importance of the social dimension of cancer. In: Heller T, Bailey L, Pattison S
(eds). Preventing cancers. London. Open University Press, 1992.
142: Olivarius F de F, Worm AM, Petersen CS, Kroon S, Lynge E. Sexual behaviour of women attending
an inner-city STD clinic before and after a general campaign for safer sex in Denmark. Genitourin Med.
1992 Oct;68(5):296-9.
141: Kolstad H, Lynge E, Olsen J, Sabroe S. Occupational causes of some rare cancers. A literature
review. Scand J Soc Med Suppl. 1992;48:1-148. Review.
140: Kjaer SK, Dahl C, Engholm G, Bock JE, Lynge E, Jensen OM. Case-control study of risk factors for
cervical neoplasia in Denmark. II. Role of sexual activity, reproductive factors, and venereal infections.
Cancer Causes Control. 1992 Jul;3(4):339-48.
139: Lynge E. Cancer morbidity by occupation. Scand J Work Environ Health. 1992;18 Suppl 1:50-6.
22
138: Ronco G, Costa G, Lynge E. Cancer risk among Danish and Italian farmers. Br J Ind Med. 1992
137: Lynge E, Engholm G, Madsen M. [The significance of organized screening for uterine cervix cancer in
Denmark during 1968-1987]. Ugeskr Laeger. 1992 May 4;154(19):1330-4.
Danish. Apr;49(4):220-5.
136: Lynge E, Poll P, Larsen J, Schultz H, Thommesen N. [Screening for uterine cervix cancer in Storstrøm,
Vestsjaelland and Bornholm counties during 1979-1989]. Ugeskr Laeger. 1992 May 4;154(19):1335-8.
Danish.
135: Lynge E, Arffmann E, Hansen KC, Henriksen B, Holten IW, Hølund B, Jespersen NB, Lindsø R, Olesen
F, Poll P, et al. [Status of preventive examinations against uterine cervix cancer in Denmark]. Ugeskr Laeger.
1992 May 4;154(19):1339-42. Danish.
134: Skov T, Hermind B, Lynge E. EC-legislation on carcinogens. (Includes database on diskette),
København: Kræftens Bekæmpelse, 1992.
133: Lynge E. Definitions and ongoing screening activities. In National Board of Health (ed). Screening, Why, When, How? København: National Board of Health, 1992; pp.12-25.
132: Skov T, Mikkelsen S, Svane O, Skov BG, Lynge E. Identifying occupational cancer. Am J Ind Med.
1992;21(2):281-5.
1991
131: Lynge E. Feasibility of the establishment of an EC-register on occupational cancer. Commission of the
European Communities. København, 1991.
130: Lynge E. Occupational mortality and cancer analysis. Public Health Rev. 1990-1991;18(2):99-116.
129: Saracci R, Kogevinas M, Bertazzi PA, Bueno de Mesquita BH, Coggon D, Green LM, Kauppinen T,
L'Abbé KA, Littorin M, Lynge E, et al. Cancer mortality in workers exposed to chlorophenoxy herbicides
and chlorophenols. Lancet. 1991 Oct 26;338(8774):1027-32.
128: Skov T, Olsen J, Rørth M, Maarup B, Winthereik H, Lynge E. [Cytostatics--work
environment. Reassuring studies--but need for more]. Sygeplejersken. 1991 Nov 27;91(48):4-7.
Danish.
127: Lynge E. [Mammography--yes or no]. Ugeskr Laeger. 1991 Oct 21;153(43):3022. Danish.
126: Kyvsgaard B, Lynge E, Olsen J. Registerforskning. Et forskerindlæg. København: Det etiske Råd, 1991.
125: Skov T, Lynge E. Non-Hodgkin's lymphoma and occupation in Denmark. Scand J Soc Med. 1991
Sep;19(3):162-9.
124: Søndergaard JO, Bülow S, Lynge E. [Occurrence of colorectal cancer among parents of patients with
this disease]. Ugeskr Laeger. 1991 Sep 16;153(38):2624-6. Danish.
123: Hémon D, Boyer J, Berrino F, Brochard P, Glass DC, Goldberg M, Kromhout H, Lynge E, Pannett B,
Segnan N, Smit HA. Retrospective evaluation of occupational exposures in cancer epidemiology: a
european concerted action of research. Appl Occup Environ Hyg 1991;6:541-6.
122: Kjaer SK, de Villiers EM, Dahl C, Engholm G, Bock JE, Vestergaard BF, Lynge E, Jensen OM. Casecontrol study of risk factors for cervical neoplasia in Denmark. I: Role of the "male factor" in women with
23
one lifetime sexual partner. Int J Cancer. 1991 Apr 22;48(1):39-44.
121: Kjaer SK, Svare EI, Haugaard BJ, Teisen C, Christensen RB, Lynge E, Jensen OM. Contraceptive use
in random samples of Greenlandic and Danish women--changes from 1986 to 1988. Scand J Soc Med. 1991
Mar;19(1):39-43.
120: Sherson D, Svane O, Lynge E. Cancer incidence among foundry workers in Denmark. Arch Environ
Health. 1991 Mar-Apr;46(2):75-81.
119: Søndergaard JO, Bülow S, Lynge E. Cancer incidence among parents of patients with colorectal
cancer. Int J Cancer. 1991 Jan 21;47(2):202-6.
118: Kjaer SK, Teisen-Simony ML, Haugaard BJ, Christensen RB, Lynge E, Jensen OM. [Choice of
contraception in relation to sexual activity among younger women in Nuuk/Godthåb (Grönland) and in
Nykøbing Falster (Danmark). A population-based cross-sectional study among 1,247 women]. Ugeskr
Laeger. 1991 Jan 21;153(4):278-81. Danish.
117: Jakobsen AKM, Bertelsen K, Andreasson B, Bichel P, Christensen JJ, Christophersen IS, Engelholm
SA, Havsteen H, Hjelm-Hansen M, Jensen F, Klitgaard D, Lynge E, Pedersen KD, Pfeiffer P. Behandlingen
af cancer cervicis uteri i Danmark. Ugeskrift for Læger. 1991;153:168-70.
1990
116: Skov T, Lynge E, Maarup B, Olsen J, Rørth M, Winthereik H. Risks for physicians
handling antineoplastic drugs. Lancet. 1990 Dec 8;336(8728):1446.
115: Hugod C, Alban A, Dehlholm G, Fog J, Hørder M, Lynge E, Olesen F, Olsen J, Møller-Pedersen K,
Worm- Petersen J. Screening. Hvorfor - Hvornår - Hvordan. Forebyggelse og hygiejne nr. 13.
København: Sundhedsstyrelsen, 1990.
114: Skov T, Mikkelsen S, Svane O, Lynge E. Reporting of occupational cancer in Denmark. Scand J Work
Environ Health. 1990 Dec;16(6):401-5.
113: Mellemgaard A, Ewertz M, Lynge E. The association between risk of breast cancer and age at
first pregnancy and parity in Maribo County, Denmark. Acta Oncol. 1990;29(6):705-8.
112: Kjaer SK, Dahl C, Bock JE, Christensen RB, Lynge E, Engholm G, Jensen OM. [Sexual habits of
women aged 20-39 years. A comparison of 3 population-based studies from Nyköbing Falster, Copenhagen
and Nuuk/Godthåb]. Ugeskr Laeger. 1990 Sep 17;152(38):2727-31. Danish.
111: Kogevinas M, Saracci R, Bertazzi PA, Bueno de Mesquita HB, Coggon D, Green LM, Johnson ES,
Kauppinen T, L'Abbé KA, Littorin M, Lynge E, Mathews JD, Neuberger M, Osman J, Pearce N,
Winkelmann R. Exposure information in the IARC international register of persons exposed to phenoxy
herbicides and contaminants. Proceedings of the 10th International Meeting, Dioxin 90' Vol I, pp. 293-6,
1990.
110: IARC Working Group. Phenoxy acid herbicides and contaminants: Description of the IARC
international register of workers. Am J Ind Med 1990; 18:39-45.
109: Lynge E, Thygesen L. Occupational cancer in Denmark. Cancer incidence in the 1970 census
population. Scand J Work Environ Health. 1990;16 Suppl 2:1-35. Review.
108: Guenel P, Engholm G, Lynge E. Laryngeal cancer in Denmark: a nationwide longitudinal study based
on register linkage data. Br J Ind Med. 1990 Jul;47(7):473-9.
24
107: Skov T, Mikkelsen S, Svane O, Lynge E. Anmeldelse af arbejdsbetinget kræft i Danmark.
København: Arbejdsmiljøfondet, Kræftens Bekæmpelse, 1990.
106: Kamper-Jørgensen F, Hansen EH, Loft A, Lynge E, Thylstrup A. Udvikling af helsetjenesteforskning i
Danmark. København: Statens Sundhedsvidenskabelige Forskningsråd, 1990.
105: Kjær SK, Poll P, Jensen H, Engholm G, Haugaard BJ, Teisen C, Christensen RB, Møller KA,
Vestergaard BF, de Villiers E-M, Lynge E, Jensen OM. Abnormal papanicolaou smear. A population-based
study of risk factors in Greenlandic and Danish women. Acta Obstet Gynecol Scand 1990;69:79-86.
104: Jensen AA, Breum NO, Bacher J, Lynge E. Occupational exposures to styrene in Denmark 1955-88. Am
J Ind Med. 1990;17(5):593-606.
103: Lynge E, Kurppa K, Kristoffersen L, Malker H, Sauli H. Occupational groups potentially exposed to
silica dust: a comparative analysis of cancer mortality and incidence based on the Nordic occupational
mortality and cancer incidence registers. IARC Sci Publ. 1990;(97):7-20.
102: Kjaer SK, Engholm G, Teisen C, Haugaard BJ, Lynge E, Christensen RB, Møller KA, Jensen H, Poll
P, Vestergaard BF, et al. Risk factors for cervical human papillomavirus and herpes simplex virus
infections in Greenland and Denmark: a population-based study. Am J Epidemiol. 1990 Apr;131(4):66982.
101: Lynge E, Thygesen L. Primary liver cancer among women in laundry and dry-cleaning work in
Denmark. Scand J Work Environ Health. 1990 Apr;16(2):108-12.
100: Lynge E. Screening - hvad gør vi? Hvad kunne vi gøre? I: Statens sundhedsvidenskabelige
Forskningsråd, Dansk Sygehus Institut (eds). Hvordan undgås kræftdødsfald? Konsensus-rapport.
København: Kræftens Bekæmpelse. 1990:59-62.
99: Lynge E. Screening. The case of cervical cancer. In: Andreasen PB, Lund AB (eds). Life-cycles of
medical technologies. Copenhagen: Academic Publishing, 1990: pp.37-43.
98: Madsen M, Olesen F, Lynge E. Cancerscreening. Månedsskr Prak Lægegern 1990;68:229-44.
97: Skov T, Andersen A, Malker H, Pukkala E, Weiner J, Lynge E. Risk for cancer of the urinary
bladder among hairdressers in the Nordic countries. Am J Ind Med. 1990;17(2):217-23.
1989
96: Lynge E, Mellemgaard A, Valentin D, Thygesen L. Stillesiddende arbejde og kræft. Månedsskr Prakt
Lægegern 1989;67:861-5.
95: Lynge E, Holm N. Cancerepidemiologi. Månedsskr Prak Lægegern 1989;67: 773-84.
94: Lynge E. The role of occupation in the causation of cancer and its prevention. In: Heller T, Davey B,
Bailey L (eds). Reducing the risk of cancers. London: Hodder & Stoughton, 1989:58-64.
93: Mellemgaard A, Jensen OM, Lynge E. Cancer incidence among spouses of patients with
colorectal cancer. Int J Cancer. 1989 Aug 15;44(2):225-8.
92: Guénel P, Højberg G, Lynge E. Cancer incidence among Danish stone workers. Scand J Work Environ
Health. 1989 Aug;15(4):265-70.
91: Guénel P, Breum NO, Lynge E. Exposure to silica dust in the Danish stone industry. Scand J Work
25
Environ Health. 1989 Apr;15(2):147-53.
90: Lynge E, Andersen O, Hörte L-G. Mortality: A comparison of within country differentials based on
selected occupational groups reported in a variety of countries. In: Fox AJ (ed). Health Inequalities in
European Countries. Alsershot: Gower Publication Company Limited, 1989: pp.163-72.
89: Kjaer SK, Teisen C, Haugaard BJ, Lynge E, Christensen RB, Møller KA, Jensen H, Poll P, Vestergaard
BF, de Villiers EM, et al. Risk factors for cervical cancer in Greenland and Denmark: a population-based
cross- sectional study. Int J Cancer. 1989 Jul 15;44(1):40-7.
88: Lynge E, Madsen M, Engholm G. Effect of organized screening on incidence and mortality of
cervical cancer in Denmark. Cancer Res. 1989 Apr 15;49(8):2157-60.
87: Bonte J, Coleman DV, Declerck A, de Oliveira CF, De Waard F, Dexeus S, Dowling M, Efstratiades M,
Elston CW, Gorins A, Hansen-Koenig D, Mouzaka L, Lynge E, Onnis A, Robra B-P, Strand M,
Vandenbroucke A, Verbeek ALM, Verellen W. Cancer prevention by mass screening for gynaecologic
cancers in the European community. Eur J Gynaec Oncol. 1989; 2:63-8.
86: Raffn E, Lynge E, Juel K, Korsgaard B. Incidence of cancer and mortality among employees in the
asbestos cement industry in Denmark. Br J Ind Med. 1989 Feb;46(2):90-6.
85: Lynge E. Screening for cancer of the cervix uteri. World J Surg. 1989 Jan-Feb;13(1):71-8. Review.
84: Bock J, Jensen OM, Kjaer SK, Lynge E, Melbye M, Norrild B. [Herpes virus infection and cancer of
the uterine cervix]. Ugeskr Laeger. 1989 Jan 16;151(3):182-3. Danish.
83: Kjaer SK, Lynge E. Incidence, prevalence and time trends of genital HPV infection determined by
clinical examination and cytology. IARC Sci Publ. 1989;(94):113-24. Review.
1988
82: Lynge E. Collection of exposure data following identification of high risk job-categories in a
nationwide surveillance system. In: Hemon D, Goldberg M, (eds). Methodology of assessment of
occupational exposures in the context of epidemiological detection of cancer risks. Brussels: Commission
of the European Community, Directorate General Science, Research and Development, 1988: pp.25-33.
81: Lynge E, Erichsen LB. Krebsforschung und registergesetz in Dänemark. Off Gesundheitswes
1988;50:395-7.
80: Guenel P, Højberg G, Breum NO, Lynge E. Cancer risk in a cohort of Danish stone workers. In: Hogstedt
C, Reuterwall C (eds). Progress in occupational epidemiology. Proceedings of the Sixth International
Symposium on Epidemiology and Occupational Health, Stockholm, Sweden, 16-19 August 1988.
Netherlands: Elsevier Science Publishers B.V., 1988: pp.111-4.
79: Gudbergsson H, Järvholm B, Kauppinen T, Kjuus H, Lynge E, Olsen J, Partanen T, Plato N, Seedorff
L. Use of job exposure matrices in the Nordic countries. Copenhagen: Danish Cancer Society, Danish
Cancer Registry, 1988.
78: Guenel P, Møller H, Lynge E. Incidence of the upper respiratory and digestive tract cancers
and consumption of alcohol and tobacco in Denmark. Scand J Soc Med. 1988;16(4):257-63.
77: Jensen OM, Lynge E, Olsen JH. Record linkage in occupational cancer epidemiology. In: Hogstedt C,
Reuterwall C (eds). Progress in occupational epidemiology. Proceedings of the Sixth International
26
Symposium on Epidemiology and Occupational Health, Stockholm, Sweden, 16-19 August 1988.
Netherlands: Elsevier Science Publishers B.V., 1988: pp.27-41.
76: Lynge E, Thygesen L. The Danish occupational cancer register. In: Nordic Statistical Secretariat.
Nordic seminar on empirical life history analysis and panel studies. Stockholm, November 25 to 27, 1987.
Tekniske rapporter no. 46. Copenhagen: 1988: pp.301-3.
75: Kjaer SK, de Villiers EM, Haugaard BJ, Christensen RB, Teisen C, Møller KA, Poll P, Jensen H,
Vestergaard BF, Lynge E, et al. Human papillomavirus, herpes simplex virus and cervical cancer incidence
in Greenland and Denmark. A population-based cross-sectional study. Int J Cancer. 1988 Apr 15;41(4):51824.
74: Lynge E, Thygesen L. Use of surveillance systems for occupational cancer: data from the Danish
National system. Int J Epidemiol. 1988 Sep;17(3):493-500.
73: Mellemgaard A, Engholm G, Lynge E. High and low risk groups for cancer of colon and rectum in
Denmark: multiplicative Poisson models applied to register linkage data. J Epidemiol Community Health.
1988 Sep;42(3):249-56.
72: Lynge E. Surveillance of occupational health. In: Eylenbosch WJ, et al (eds). Surveillance in Health and
Disease. Oxford University Press, 1988: pp.183-90.
1987
71: Ewerts M, Lynge E, Madsen M, Jensen OM. [Screening for breast cancer: effect on mortality]. Ugeskr
Laeger. 1987 Oct 26;149(44):2995-9. Danish.
70: Lynge E, Storm HH, Jensen OM. The evaluation of trends in soft tissue sarcoma according to
diagnostic criteria and consumption of phenoxy herbicides. Cancer. 1987 Oct 15;60(8):1896-901. Review.
69: Kjaer S, Lynge E, Bock J. [Potential risk factors in cervix cancer—a case-control study of stress on
"the male factor"]. Ugeskr Laeger. 1987 Sep 14;149(38):2569. Danish.
68: Madsen M, Lynge E. [Mortality of cervix cancer in Denmark 1943-1982]. Ugeskr Laeger. 1987 Jul
20;149(30):2038-43. Danish.
67: Lynge E, Juel K. Use of public pension scheme and industrial statistics data for supplement of
company records in Denmark and influence on cohort mortality pattern. J Occup Med. 1987
May;29(5):430-2.
66: Mellemgaard A, Lynge E. [Colorectal cancer in Denmark 1943-1982. Cancer statistics no. 16]. Ugeskr
Laeger. 1987 Jan 12;149(3):188-91. Danish.
65: Lynge E. Background and design of a Danish cohort study of workers in phenoxy herbicide
manufacture. Am J Ind Med. 1987;11(4):427-37.
64:Lynge E. Evaluation of screening for cervical cancer in Denmark. Sozialmedizin Schwerpunkte:
Rheuma und Krebs. Springer-Verlag 1987, pp. 197-202.
63: Jensen OM, Olsen JH, Lynge E. The cancer registry and the study of occupational cancer in
Denmark. Gann Monogr 1987;33:65-72.
62: Olsen J, Skytthe A, Lynge E, Knudsen L, Svane O. Udvikling af en dansk jobeksponeringsmatrice. København: Kræftens Bekæmpelse, 1987.
27
61: Raffn E, Lynge E, Juel K, Korsgaard B. Kræftrisiko og dødelighed blandt ansatte på en
dansk asbestcementfabrik. København: Kræftens Bekæmpelse, 1987.
1986
60: Lynge E, Kurppa K, Kristofersen L, Malker H, Sauli H. Silica dust and lung cancer: results from the
Nordic occupational mortality and cancer incidence registers. J Natl Cancer Inst. 1986 Oct;77(4):883-9.
59: Jørgensen F, Lynge E. [Bladder cancer in a limited region]. Ugeskr Laeger. 1986 Sep 29;148(40):25712. Danish.
58: Storm HH, Lynge E, Osterlind A, Jensen OM. Multiple primary cancers in Denmark 1943-80; influence
of possible underreporting and suggested risk factors. Yale J Biol Med. 1986 Sep-Oct;59(5):547-59.
57: Lynge E, Poll P. Incidence of cervical cancer following negative smear. A cohort study from Maribo
County, Denmark. Am J Epidemiol. 1986 Sep;124(3):345-52. Erratum in: Am J Epidemiol. 2008
Jul;143(7):707.
56: Pociot F, Storm HH, Lynge E. [Mammographic examinations in Denmark in 1984]. Ugeskr Laeger. 1986
Feb 17;148(8):471-4. Danish.
55: Lynge E, Poll P. Risk of cervical cancer following negative smears in Maribo County, Denmark, 19661982. IARC Sci Publ. 1986;(76):69-86.
54: Lynge E. Experience in registration of cancer incidence from the Danish Cancer Registry. In van Reek J,
Veys D (eds). Proceedings. Workshop on morbidity and mortality registration of chronic diseases.
Maastricht,
1986.
53: Lynge E. Er faldet i incidensen af livmoderhalskræft i Danmark et resultat af screeningsaktiviteten? I: Juul
S, Pedersen KM (eds). Metoder til vurdering af effekten af folkeundersøgelser. SLF-rapport. København,
1986.
52: IARC-working group on evaluation of cervical cancer screening programmes. Screening for squamous
cervical cancer: duration of low risk after negative results of cervical cytology and its implication for
screening policies. Br Med J 1986;293:659-64.
51: Lynge E. Exposure of the working population in Denmark to chemicals or processes considered as being
potentially carcinogenic. In: IARC. Priorities in occupational cancer epidemiology. Internal Technical
Report No. 86/001. Lyon, 1986.
1985
50: Storm HH, Jensen OM, Ewertz M, Lynge E, Olsen JH, Schou G, Osterlind A. Summary: multiple
primary cancers in Denmark, 1943-80. Natl Cancer Inst Monogr. 1985 Dec;68:411-30.
49: Osterlind A, Olsen JH, Lynge E, Ewertz M. Second cancer following cutaneous melanoma and cancers
of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80. Natl Cancer Inst Monogr. 1985
Dec;68:361-88.
48: Lynge E, Jensen OM, Carstensen B. Second cancer following cancer of the digestive system in Denmark,
1943-80. Natl Cancer Inst Monogr. 1985 Dec;68:277-308.
47: Lynge E. A follow-up study of cancer incidence among workers in manufacture of phenoxy herbicides in
Denmark. Br J Cancer. 1985 Aug;52(2):259-70.
46: Lynge E, Jensen OM. Cohort trends in incidence of cervical cancer in Denmark in relation to
28
gonorrheal infection. Acta Obstet Gynecol Scand. 1985;64(4):291-6.
45: Olsen JH, Lynge E. Forebyggelse af Cancer. Bibl Læger 1985;177/2:211-9.
44: Lynge E, Berget A. Cervixcancer og screening i Danmark. Månedsskr Prakt Lægegern 1985;7:499-504.
1984
43: Lynge E, Storm HH. [Cervix cancer and cervical prenecroses in Denmark 1943-1982. Cancer statistics No.
12]. Ugeskr Laeger. 1984 Nov 5;146(45):3483-7. Danish.
42: Lynge E. [Geographical differences in cervix cytology screening and the incidence of cervix cancer 19431982]. Ugeskr Laeger. 1984 Nov 5;146(45):3477-82. Danish.
41: Lynge E. Socioeconomic and occupational mortality differentials in Europe. Soz Praventivmed.
1984;29(6):265-7.
40: Jensen OM, Lynge E. The contribution of epidemiology to the study of occupational cancer. J Cancer Res
Clin Oncol. 1984;108(3):257-63.
39: Lynge E, Berget A. Cervical cancer and screening in Denmark. Huisarts Wet 1984;27:412-4.
38: Lynge E, Storm HH. Cervixcancer og cervikale prækankroser. Epidemiologi. I: Bock JE (ed).
Prækankroser i gynækologien. København: FADL, 1984: pp.19-28.
37: Lynge E. Ukrudtsmidler og kræft. København: Arbejdsmiljøfondet, 1984.
36: Lynge E. Socio-economic differences in mortality in Europe. Population Studies no. 9.
Strassbourg: Council of Europe, 1984.
35: Lynge E. Personregistre: Dit liv gennemskuet - på godt og ondt. Naturkampen 1984;30/1:22-5.
34: Lynge E. Trends and perspectives in mortality. In: Lopez AD, Cliquet RL (eds). Demographic trends in the
European Region. WHO Regional Publications, European Series no. 17; Copenhagen, 1984: pp.117-32.
33: Lynge E. Experiences in estimating differentials in mortality in developed countries - achievements and
shortcomings of the various approaches. In: United Nations, Department of International Economic and
Social Affairs (ed). Data Bases for mortality measurement. Population Studies no. 84. New York, 1984:
pp.117-26.
1983
32: Lynge E. Regional trends in incidence of cervical cancer in Denmark in relation to local smeartaking activity. Int J Epidemiol. 1983 Dec;12(4):405-13.
31: Lynge E, Olsen JH, Jensen OM. [What do we know about occupational cancer?]. Ugeskr Laeger. 1983
Nov 14;145(46):3583-6. Danish.
30: Lynge E, Andersen O, Kristensen TS. Lung cancer in Danish butchers. Lancet. 1983 Mar 5;1(8323):527-8.
29: Lynge E, Jeune B. Excess mortality among male unskilled and semi-skilled workers. A negative slope
with age. Scand J Soc Med. 1983;11(2):37-40.
28: Andersen O, Lynge E, Olsen J. Analysis of available statistical sources for the detection of
occupational cancer harzards. London 15-18.XII. 1982. Ugeskrift for Læger 1983;145:603.
27: Olsen J, Skytthe A, Lynge E, Knudsen L, Svane O. Udvikling af en dansk Jobeksponeringsmatrice. Ugeskrift for Læger 1983;145:4036-7.
29
26: Lynge E, Jensen OM. Rationel screening for livmoderhalskræft? Ugeskrift for Læger 1983;145:1414-5.
25: Jensen OM, Lynge E. Job exposure Linkage Systems for Cancer Research in Scandinavia. In: Acheson
D (ed). Job Exposure Matrices. Medical Research Council, Environmental Epidemiology Unit. University
of Southampton. Scientific Report no. 2. Southampton, 1983: pp.15-21.
24: Lynge E. Problems of data collection in morbidity and mortality statistics. In: Universite Catholique de
Louvain. Departement de Demographie (ed). Morbidity et mortalite aux ages adultes dans les pays
developpes. Louvain, 1983: pp.41-60.
1982
23: Fox AJ, Lynge E, Malker H. Lung cancer in butchers. Lancet. 1982 Jan 16;1(8264):165-6.
22: Lynge E. [Vaginal cytological examinations in Denmark]. Ugeskr Laeger. 1982 Jan 11;144(2):124-9.
Danish.
21: Lynge E, Jeune B. Mortality studies in unskilled and semi-skilled workers in Denmark. A comparative
analysis. Scand J Soc Med. 1982;10(3):77-80.
20: Lynge E, Jensen OM, Svane O. Conference on job-exposure matrices. Southampton 19-21.IV. 1982.
Ugeskrift for Læger 1982;144:1577-8.
19: Lynge E. Epidemiologiske undersøgelser af fenoxykarbonsyres carcinogene effekt. I: Arbejdstilsynet
(ed). Rapport vedrørende fenoxysyrer og klorfenoler. København, 1982: pp.47-69.
18: Lynge E. The Danish Occupational Cancer Study. In: ILO, WHO, Institute of Occupational Health (eds).
Proceedings from the International Symposium on Prevention of Occupational Cancer. Geneva, 1982: pp.55768.
1981
17: Lynge E. Occupational mortality in Norway, Denmark and Finland, 1971-1975. In: UN, WHO, CICRED
(eds). Socioeconomic Differential Mortality in Industrialized Societies. Vol. 1. Paris, 1981: pp.13-39.
1980
16:Lynge E. Dødelighed blandt slagteriarbejdere. Pas på 1980;9:29-30.
15:Lynge E. Dødelighed og erhverv. Pas på 1980;9:21-3.
1979
14: Lynge E. Ufaglærte arbejdere har størst risiko for at dø inden pensionsalderen. Forskning og Samfund
1979;5/7:9-11.
13:Lynge E. Occupational mortality in Denmark 1970-1975. Scand Pop St 1979; 5:120-30.
12:Danmarks Statistik. Dødelighed og erhverv 1970-75. Statistiske Undersøgelser nr. 37, København, 1979.
11:Lynge E. Identifikation af risikogrupper på grundlag af folketællings klassifikationer. I: Jepsen J, Olsen J,
Viskum P (eds). Dataindsamling i arbejdsmedicinen. Formål og metoder. København: Arbejdsmiljøfondet,
1979: pp.31-49.
10:Lynge E. Sundhedsvæsenets finansiering og styring samt Sundhedstilstandens udvikling. I:
Socialmedicinsk Institut, Århus Universitet. Medicinsk sociologi. Udgivelse nr. 20, Århus, 1979: pp.381-439.
30
1977
9: Foldspang A, Jeune B, Lynge E, Mikkelsen S, Olsen J, Sidenius K, Sorensen HH. [Occupational mortality
statistics in England. A review]. Ugeskr Laeger. 1977 Apr 18;139(16):966-70. Danish.
8: Lynge E. To artikler om erhverv og dødelighed. Socialmedicinsk Institut, Århus Universitet. Udgivelse nr.
15. Århus, 1977.
1976
7: Lynge E. Krise og sundhedspolitik. Skitse til en forståelse af den statslige sundhedsplanlægning. I: Danske
Studenters Fællesråd (ed). Fagkritik inden for sundhedsuddannelserne. København: DSF, 1976: pp.219-52.
1975
6: Block Jespersen N, Lynge E. Arbejds- og helbredsforhold hos hyrevognschauffører. Institut for social
medicin, Københavns Universitet, 1975.
1974
5: Lynge E. Dødelighed i Danmark 1951-71. Magisterkonferens. Sociologisk Institut, Københavns
Universitet, 1974.
1972
4:Lynge E, Posborg R. Om socialpolitik. Socialrådgiveren 1972;34:97-102.
1971
3: Lynge E. Arbejdssygdomme i politisk-økonomisk perspektiv. I: Gregersen P, Hoffmeyer J, Iversen L,
Jansson P, Lynge E, Mikkelsen S (eds). Sygdom i samfundet. København, 1971: pp.40-79.
2: Lynge E. Arbejdsulykkesstatistikken. Ugeskrift for Læger 1971;133:1572-4.
1970
1: Gannik D, Lynge E. [Sociological students as interns in clinical departments. Report of an experiment].
Ugeskr Laeger. 1970 Jun 18;132(25):1202-3. Danish.
31